- View programme as: Grid view List view
- Print: Print
- Search
- Personal Planner
Sun 22 March
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Grey Area, Room G105
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Grey Area, Room G105
-
ESU Course 39 - Management of BPO: From medical to surgical treatment, including setbacks and operative solutions (SOS)
Management of BPO: From medical to surgical treatment, including setbacks and operative solutions (SOS) ESU Course 39
Management of BPO: From medical to surgical treatment, including setbacks and operative solutions (SOS)
ESU Course 39
-
Location:Grey Area, Room G105
-
Chair:
-
Learning objectives • To help delegates understand the principles and evidence behind the assessment and medical management of a BPO patient.
• To summarise / review the evidence base for electro surgery and lasers for surgical management of BPO.
• To help delegates understand the factors that influence the patient’s and surgeon’s choice of treatment modalities.
• Setbacks and Operative Solutions (SOS): Tips and Tricks to improve outcomes and avoid complications.
Introduction/scene setting BPO 2020 To be confirmed
Assessment and medical management To be confirmed
-
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Orange Area, eURO Auditorium 1
-
Orange Area, eURO Auditorium 2
-
Green Area, Room 1
-
Green Area, Room 2
-
Green Area, Room 3
-
Green Area, Room 4
-
Green Area, Room 5
-
Purple Area, Room Elicium 1
-
Purple Area, Room Elicium 2
-
Grey Area, RAI Auditorium
-
Yellow Area, Room Forum
-
Grey Area, Room Emerald
-
Yellow Area, Room E102
-
Yellow Area, Room E103
-
Green Area, Room A
-
Green Area, Room B
-
Grey Area, Room G102
-
Grey Area, Room G103
-
Grey Area, Room G104
-
Grey Area, Room G105
-
Grey Area, Room G106
-
Grey Area, Room G107
-
Grey Area, Room G108
-
Grey Area, Room G109
-
Grey Area, Room G002
-
Orange Area, Room 1
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Orange Area, eURO Auditorium 1
-
Game changer session
Game changer session
-
Game changer session
Game changer session
-
Plenary session 3 - Modern prostate cancer imaging in daily practice
Modern prostate cancer imaging in daily practice Plenary session 3
Modern prostate cancer imaging in daily practice
Plenary session 3
When not to biopsy? Imaging and genomics in the diagnosis of prostate cancer Problems with imaging in real life Case discussion Turning bright spots into meaningful action -
Plenary session 5 - Challenges across the spectrum of bladder cancer
Challenges across the spectrum of bladder cancer Plenary session 5
Challenges across the spectrum of bladder cancer
Plenary session 5
-
Location:Orange Area, eURO Auditorium 1
-
Chairs:
-
Learning objectives Clinical decision making for non muscle-invasive bladder cancer and new tools for adjuvant treatment for these tumors take a large part of this session. Furthermore an optimization in the selection of elderly patients with advanced bladder cancer for surgical vs. conservative treatment will be presented. One part of the session deals with personalized treatment and its underlying genetic testing in bladder cancer.
Debate Early cystectomy in high-risk NMIBC: A standard? Discussion
-
-
Plenary session 7 - Stones: The role of innovation
Stones: The role of innovation Plenary session 7
Stones: The role of innovation
Plenary session 7
-
Location:Orange Area, eURO Auditorium 1
-
Chairs:
-
Learning objectives Today, stone treatment means endourology in most cases. New endoscopes, new lasers, new disposables promise better efficacy, lower morbidity and shorter hospital stays. Is this all true or are there potential drawbacks to be considered? Which protocols and treatment algorithms lead to the best treatment results? This plenary will give answers.
Round-table discussion Perioperative Antibiotic Prophylaxis: When, how and how long? Debate New technology in retrograde intrarenal surgery: Unnecessary luxury vs measurable benefit Round-table discussion Beyond holmium laser: New lithotripsy devices Round-table discussion 1cm stone in the lower calyx plus 2cm upper ureteral stone with complete obstruction Souvenir session -
-
Plenary Session 1 - New frontiers in infections
New frontiers in infections Plenary Session 1
New frontiers in infections
Plenary Session 1
-
Location:Orange Area, eURO Auditorium 1
-
Chairs:
-
Learning objectives Urological infections become more and more difficult to treat, due to the fact that on the one hand antimicrobial resistance and multiresistance emerge dramatically in causative pathogens on a global level and antibiotics are increasingly restricted. On the other hand urological patients do have more and more accompanying morbidities. This session deals with the most important and recent aspects and strategies that deal with the challenges of antimicrobial resistance, from prevention and prophylaxis to treatment of life threatening infections.
How to minimise infectious complications of prostate biopsies: A white paper Debate Infection control practices in patients at risk for multiresistant pathogens -
-
Meeting of the EAU Section of Uro-Technology (ESUT), in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS) - Technology developments never ends!
Technology developments never ends! Meeting of the EAU Section of Uro-Technology (ESUT), in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
Technology developments never ends!
Meeting of the EAU Section of Uro-Technology (ESUT), in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
Live broadcasts from Academic Medical Center, Amsterdam (NL) Patient advocates
Live surgery - Part I Pre-recorded video To be confirmedLive surgery - Part II Pre-recorded video Robot-assisted endoscopic extraperitoneal radical prostatectomy with the Senhance digital platform To be confirmed
Live surgery - Part III Pre-recorded video Single Port RARP To be confirmed
Pre-recorded video To be confirmedLive surgery To be confirmed
Retrograde intra renal surgery for stones To be confirmed
Pre-recorded video Rezum™ for prostate treatment To be confirmed
Live surgery - Part IV Pre-recorded video Intracorporeal neobladder using robotic stapler To be confirmed
-
Video Session 07 - Evolving techniques in upper urinary tract surgery
Evolving techniques in upper urinary tract surgery Video Session 07
Evolving techniques in upper urinary tract surgery
Video Session 07
V046Patient care pathway hypnosedation in endo urology: An innovative alternative to general anesthesia
By: Fakhfakh S. 1 , Pouliquen C. 2 , Campagna J. 1 , Loverde K. 1 , Treacy P. 1 , Maubon T. 1 , Rybikowski S. 1 , Cambon S. 2 , Nguyen L. 2 , Deguibert J. 2 , Laurent M.A. 3 , Aveno J. 3 , Bokor E. 3 , Demontis C. 3 , Forestier C. 3 , Bereni F. 3 , Galland J. 3 , Montoya C. 3 , Mejri I. 3 , Cea C. 3 , Faucher M. 2 , Mokart D. 4 , Pignot G. 1 , Walz J. 1
Institutes: 1Institut Paoli Calmettes, Dept. of Urology, Marseille, France, 2Institut Paoli Calmettes, Dept. of Anesthesiology, Marseille, France, 3Institut Paoli Calmettes, Dept. of Operating theatre, Marseille, France, 4Institut Paoli Calmettes, Dept. of Reanimation, Marseille, France
V047Cold en bloc excision of non muscle invasive bladder cancer less than 3cm using a novel Zedd scissors: Our initial experience
By: Hameed B.M.Z. , Shah M. , Thomas J.
Institutes: KMC Manipal, Dept. of Urology, Manipal, India
V048Percutaneous treatment of pelvis-calyceal nephrogenic adenoma: Technique description
By: Melgarejo Segura M.T. , Cano-García M.C. , Garcia-Lopez C. , Jimenez-Pacheco A. , Morales-Martinez A. , Arrabal-Martin M. , Arrabal-Polo M.A.
Institutes: Hospital Universitario Clinico San Cecilio, Dept. of Urology, Granada, Spain
V049Testing feasibility of an accurate microscopic assessment of urological specimens by smartphone add-on lenses
By: Dal Moro F. 1 , Valotto C. 1 , Di Loreto C. 2 , Proietti Zaccaria R. 3 , Bo J. 3 , Antonini A. 3
Institutes: 1University of Udine, Dept. of Urology, Udine, Italy, 2University of Udine, Dept. of Pathology, Udine, Italy, 3IIT, Italian Institute of Technology, Dept. of Smartmicrooptics, Genova, Italy
V050Dual thulium-holmium laser ablation by percutaneous approach of upper tract urinary carcinoma in a solitary kidney: An imperative case
By: Martinez C. 1 , Angerri O. 2 , Territo A. 1 , Vanacore D. 1 , Saitta G. 1 , Talle M. 1 , Caillabet A. 1 , Meneghetti I. 1 , Bevilacqua G. 1 , Montaño B. 1 , Giron I. 1 , Palou J. 1 , Breda A. 1
Institutes: 1Fundacio Puigvert, Dept. of Uro-Oncology and Kidney Transplant, Barcelona, Spain, 2Fundacio Puigvert, Dept. of Urolithiasis, Barcelona, Spain
V051Evolving techniques of endoscopic UTUC management: Optimising outcomes with the appropriate use of latest technologies
By: Vanacore D. , Sanguedolce F. , Territo A. , Montaño Roca B.E. , Saitta G. , Tallè M. , Martinez C. , Mosquera L. , Meneghetti J. , Bevilacqua G. , Gallioli A. , Boissier R. , Gaya J.M. , Palou J. , Breda A.
Institutes: Fundaciò Puigvert. Universidad Autónoma de Barcelona. Barcelona. España, Dept. of Urology, Barcelona, Spain
V052Allium ureteral stents: A critical analysis of our cases
By: Sampogna G. , Albo G. , Zanetti S.P. , Rocchini L. , Fontana M. , De Lorenzis E. , Boeri L. , Gallioli A. , Longo F. , Montanari E.
Institutes: Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Dept. of Urology, Milan, Italy
-
Video Session 10 - Meeting the challenges of partial nephrectomy
Meeting the challenges of partial nephrectomy Video Session 10
Meeting the challenges of partial nephrectomy
Video Session 10
V068The role of Indocyanine Green (ICG) in guiding robot-assisted partial nephrectomy: A prospective multi-institutional TRONES study
By: Diana P. 1 , Lughezzani G. 2 , Dell'oglio P. 3 , Mazzone E. 4 , Mottrie A. 5 , Porter J. 6 , Buffi N.M. 2
Institutes: 1IRCCS, Humanitas Clinical and Research Institute, Dept. of Urology, Rozzano, Italy, 2IRCCS, Humanitas Clinical and Research Institute, Humanitas University, Dept. of Urology, Rozzano, Italy, 3Niguarda Hospital, Dept. of Urology, Milan, Italy, 4URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Dept. of Urology, Milan, Italy, 5Onze Lieve Vrouw Hospital, ORSI Academy, Dept. of Urology, Aalst/Melle, Belgium, 6Swedish Urology Group, Dept. of Urology, Seattle, Italy
V069ICG-guided robotic-assisted partial adrenalectomy
By: Ferriero M.C. , Mastroianni R. , Tuderti G. , Anceschi U. , Bove A. , Brassetti A. , Guaglianone S. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
V070Robotic partial nephrectomy for complex hilar tumors: tips & tricks
By: Bauza Quetglas J.L. 1 , Pieras E. 1 , Murthy P. 2 , Tubau V. 1 , De La Cruz M. 1 , Martínez A. 1 , Guimerà J. 1 , Sagalovich D. 2 , Bertolo R. 2 , Kaouk J. 2
Institutes: 1Son Espases University Hospital, Dept. of Urology, Palma, Spain, 2Glickman Urological & Kidney Institute - Cleveland Clinic, Center for laparoscopic and robotic surgery, Ohio, United States of America
V071Preservation of vascularized cortex using virtual partial nephrectomy imaging during robot-assisted partial nephrectomy
By: Izumi K. , Kawanishi Y. , Yamanaka M. , Kawanishi S. , Fukawa T. , Kanayama H.
Institutes: Takamatsu Red Cross Hospital, Dept. of Urology, Takamatsu, Japan
V072Rapid segmentation of renal tumours to calculate volume using 3D interpolation
By: Chen M.Y-C. 1 , Woodruff M.A. 2 , Rukin N.J. 1
Institutes: 1Redcliffe Hospital, Dept. of Urology, Brisbane, Australia, 2Queensland University of Technology, Science and Engineering Faculty, Brisbane, Australia
V073How far is too far? Exploring the indication for partial nephrectomy in highly complex kidney tumors
By: Minervini A. , Grosso A.A. , Vittori G. , Di Maida F. , Muto G. , Carini M.
Institutes: University of Florence, Department of Oncologic, Minimally-invasive Urology and Andrology, Florence, Italy
V074Multiple partial nephrectomy for multifocal synchronous renal cancer in a solitary kidney
By: Picola Brau N. 1 , Rivero Belenchón I. 2 , Mercader Barrull C. 3 , Benfante N. 4 , Vigués Julià F. 1 , Apatov S. 4 , Russo P. 4 , Coleman J. 4 , Touijer K. 4
Institutes: 1Bellvitge University Hospital, Dept. of Urology, Barcelona, Spain, 2Virgen del Rocío University Hospital, Dept. of Uro-Nephrology, Seville, Spain, 3Clinic Barcelona University Hospital, Dept. of Urology, Barcelona, Spain, 4Memorial Sloan Kettering Cancer Center, Dept. of Urology, New York, United States of America
-
Video Session 12 - Challenging kidney surgery
Challenging kidney surgery Video Session 12
Challenging kidney surgery
Video Session 12
V082Pushing the limits of robotic assisted partial nephrectomy: Off-clamp approach for bilateral, hilar and totally endophytic renal masses
By: Ferriero M.C. , Mastroianni R. , Tuderti G. , Anceschi U. , Bove A. , Brassetti A. , Guaglianone S. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
V083Robot assisted right radical nephrectomy with level ii inferior vena cava tumor thrombectomy: The video demonstration
By: Dev P. , Yuvaraja T.B. , Santosh W. , Pednekar A.
Institutes: Kokilaben Dhirubhai Ambani Hospital, Dept. of Robotic Surgery and Uro-Oncology, Mumbai, India
V084Thrombectomy and cavoraphy performed totally intracorporeal with a 3D laparoscopic approach in treating T3a and T3b renal cell carcinoma
By: Bujoreanu E.C. , Hardo V.V. , Maris C.V. , Petrut B.
Institutes: Prof. Dr. Ion Chiricuță Institute of Oncology, Dept. of Urology, Cluj Napoca, Romania
V085Off-clamp robot-assisted partial nephrectomy for ct2 renal cancers
By: Brassetti A. , Tuderti G. , Misuraca L. , Minisola F. , Ferriero M. , Mastroianni R. , Flammia R.S. , Guaglianone S. , Anceschi U. , Costantini M. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
V086Renal cell carcinoma with level IV thrombosis. Radical nephrectomy without cardiopulmonary bypass: A series at our institution
By: Testino N. 1 , Parodi S. 1 , Tappero S. 1 , Morelli N. 2 , Terrone C. 1
Institutes: 1Ospedale Policlinico San Martino, Dept. of Urology, Genoa, Italy, 2Ospedale Policlinico San Martino, Department of General Surgery, Genoa, Italy
V087Robot-assisted laparoscopic cavectomy without IVC replacement for right RCC and inferior vena cava thrombus
By: Olivero A. 1 , Huang Q. 2 , Fan Y. 2 , Wang B. 2 , Ma X. 2 , Zhang X. 2
Institutes: 1San Martino Policlinico Hospital, IRCCS for Oncology, Dept. of Urology, Genova, Italy, 2Chinese PLA General Hospital/PLA Medical School, Beijing, Dept. of Urology, Beijing, China
-
Video Session 08 - Award winning video session
Award winning video session Video Session 08
Award winning video session
Video Session 08
V0533D augmented reality robot-assisted radical prostatectomy: The computer vision algorithm allows to identify the extracapsular extension on neurovascular bundles
By: Porpiglia F. 1 , Checcucci E. 1 , Amparore D. 1 , Piana A. 1 , Piramide F. 1 , Volpi G. 1 , De Cillis S. 1 , Manfredi M. 1 , Piazzolla P. 2 , Fiori C. 1 , Vezzetti E. 2
Institutes: 1AOU San Luigi Gonzaga, University of Turin, Dept. of Urology, Orbassano, Italy, 2Politecnico di Torino, Dept. of Management and Production Engineering, Turin, Italy
V055The new adjustable artificial sphincter victo: Surgical technique and results after a follow-up of more than one year
By: Ameli G. , Weibl P. , Rutkowski M. , Hübner W.A.
Institutes: Clinic of Korneuburg, Dept. of Urology, Korneuburg, Austria
V057Safety and short-term oncological outcomes of thulium fiber laser en-bloc resection of non-muscle-invasive bladder cancer: A prospective non-randomized phase II trial
By: Enikeev D. 1 , Taratkin M. 1 , Laukhtina E. 1 , Sukhanov R. 1 , Dymov A. 1 , Sorokin N. 2 , Shariat S.F. 3 , Glybochko P. 1
Institutes: 1Sechenov University, Institute for Urology and Reproductive Health, Moscow, Russia, 2Moscow State University, Dept. of Urology, Moscow, Russia, 3Medical University of Vienna, Dept. of Urology, Vienna, Austria
V058Double-face augmentation urethroplasty for bulbar urethral strictures-dorsal versus ventral approach: Technical implications and short-term outcomes
By: Enganti B. , Chiruvella M. , Bendigeri M.T. , Ghouse S.M. , Ragoori D. , Reddy P.C. , Pandya S.
Institutes: Asian Institute of Nephrology & Urology, Dept. of Urology, Hyderabad, India
V059Innovations and technical variations in robot-assisted kidney transplantation: Results from the ERUS working group
By: Gallioli A. 1 , Boissier R. 1 , Territo A. 1 , Campi R. 2 , Vignolini G. 2 , Musquera M. 3 , Alcaraz A. 3 , Decaestecker K. 4 , Tugcu V. 5 , Vanacore D. 1 , Serni S. 2 , Breda A. 1
Institutes: 1Fundacio Puigvert, Dept. of Urology, Barcelona, Spain, 2Careggi Hospital, University of Florence, Dept. of Urology, Florence, Italy, 3Hospital Clinic, Dept. of Urology, Barcelona, Spain, 4Ghent University Hospital, Dept. of Urology, Ghent, Belgium, 5Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Dept. of Urology, Istanbul, Turkey
-
Video Session 09 - Advanced reconstructive surgery
Advanced reconstructive surgery Video Session 09
Advanced reconstructive surgery
Video Session 09
V061Robot-assisted laparoscopic continent cutaneous urinary diversion (Mitrofanoff and Yang-Monti conduits) in a consecutive series of 8 adult patients. Surgical technique and initial outcomes: A mitrofanoff with bladder augmentation procedure
By: Loubersac T. , Branchereau J. , Bouchot O. , Rigaud J. , Glemain P. , Karam G. , Le Normand L. , Perrouin-Verbe M-A.
Institutes: CHU Nantes, Dept. of Urology, Nantes, France
V062Use of Indocyanine Green (ICG) in reconstructive robotic urology: A multi-institutional study of the ERUS reconstructive scientific working group
By: Diana P. 1 , Buffi N.M. 2 , Lughezzani G. 2 , Ploumidis A. 3 , Pappas A. 3 , Schregel C. 4 , Rochat C. 5 , Kroepfl D. 6 , Wiklund P. 7 , Mottrie A. 8 , John H. 9
Institutes: 1IRCCS, Humanitas Clinical and Research Institute, Dept. of Urology, Rozzano, Italy, 2IRCCS Humanitas Clinical and Research Institute, Humanitas University, Dept. of Urology, Rozzano, Italy, 3Athens medical centre, Dept. of Urology, Athens, Greece, 4Kantonsspital Winterthur, Dept. of Urology, Winterthur, Switzerland, 5Clinique Générale Beaulieu, Dept. of Urology, Geneva, Switzerland, 6Kliniken Essen-Mitte, Dept. of Urology, Essen, Germany, 7Karolinska University Hospital, Dept. of Urology, Stockholm, Sweden, 8Onze Lieve Vrouw Hospital, ORSI Academy, Dept. of Urology, Aalst/Melle, Belgium, 9Klinik für Urologie, Dept. of Urology, Zurich, Switzerland
V063Robot-assisted laparoscopic continent cutaneaous urinary diversion (Mitrofanoff and Yang-Monti conduits) in a consecutive series of 8 adults patients: surgical technique and initial outcomes - a Yang-Monti modified casale procedure
By: Loubersac T. , Branchereau J.B. , Bouchot O.B. , Rigaud J.R. , Karam G.K. , Glemain P. , Le Normand L.L. , Perrouin-Verbe M.A.P.V.
Institutes: CHU of Nantes, Dept. of Urology, Nantes, France
V064Totally intracorporeal robot-assisted kidney auto-transplantation
By: Van Praet C. 1 , Van Parys B. 1 , Desender L. 2 , Decaestecker K. 1
Institutes: 1Ghent University Hospital, Dept. of Urology, Ghent, Belgium, 2Ghent University Hospital, Thoracic and Vascular Surgery, Ghent, Belgium
V065Robotic ileal neoureter and psoas hitch for iatrogenic complete ureteral avulsion: Our 2 cases experience
By: Pacchetti A. 1 , Balzarini F. 1 , Caviglia A. 1 , Barabino E. 2 , Olivero A. 1 , Valcalda M. 1 , Camerini G. 3 , Terrone C. 1
Institutes: 1Ospedale Policlinico San Martino - University of Genoa, Dept. of Urology, Genoa, Italy, 2Ospedale Policlinico San Martino - University of Genoa, Dept. of Radiology, Genoa, Italy, 3Ospedale Policlinico San Martino - University of Genoa, Dept. of General Surgery, Genoa, Italy
V066Robot-assisted tension free surgery in distal ureteral disease
By: Palagonia E. 1 , Wisz P. 2 , Mazzone E. 2 , Beato S. 2 , Andras J. 2 , Poeleart F. 2 , De Groote R. 2 , Schatteman P. 2 , D'hondt F. 2 , De Naeyer G. 2 , Dell'oglio P. 2 , Mottrie A. 2
Institutes: 1OLV Aalst, ORSI Academy , Dept. of Urology, Aalst, Belgium, 2OLV Aalst, ORSI Academy, Dept. of Urology, Aalst, Belgium
V067Robot-assisted bilateral ileal ureteral substitution of long segment ureter strictures
By: Oelke M. , Oelke M. , Witt J.H.
Institutes: St. Antonius Hospital, Dept. of Urology, Gronau, Germany
-
Video Session 14 - Technological solutions for BPH
Technological solutions for BPH Video Session 14
Technological solutions for BPH
Video Session 14
V099Minimizing post-operative stress urinary incontinence after HoLEP: our preliminary experience and short-term results of ‘’En Bloc’’ technique with early apical release
By: Tuccio A. , Tellini R. , Salvi M. , Verrienti P. , Sessa F. , Di Camillo M. , Grosso A.A. , Viola L. , Mormile N. , Mari A. , Di Maida F. , Minervini A. , Carini M.
Institutes: Careggi Hospital, University of Florence, Dept. of Oncologic, Minimally-Invasive Urology and Andrology, Florence, Italy
V100Redo en bloc HoLEP with early apical release for prostate adenomatous remnants
By: Rodriguez Socarrás M. , Michel Mercado I. , Cuadros Rivera V. , Fernández Del Álamo J. , Gómez Rivas J. , Reinoso Elbers J. , Llanes González L. , Juarez Del Dago P. , Gomez Sancha F.
Institutes: ICUA Clínica CEMTRO, Dept. of Urology, Madrid, Spain
V101Prospective randomized study of monopolar enucleation vs transurethral resection of the prostate: two year follow up
By: Enikeev D. 1 , Rapoport L. 1 , Gazimiev M. 1 , Taratkin M. 1 , Laukhtina E. 1 , Sung J.M. 2 , Okhunov Z. 2 , Glybochko P. 1
Institutes: 1Sechenov University, Institute for Urology and Reproductive Health, Moscow, Russia, 2University of California, Dept. of Urology, Irvine, United States of America
V102Laparoscopic simple prostatectomy: Description of the surgical steps and outcomes
By: Dalpiaz O. , Alber T.A.
Institutes: LKH Hochsteiermark, Dept. of Urology, Leoben, Austria
V103“Pretransection of urethral mucosa at the apex of prostate” holmium laser enucleation of the prostate: A modified en bloc technique for transurethral anatomic prostatectomy
By: Wu J. , Yongbao W. , Le L. , Tao L. , Qingguo Z. , Liefu Y.
Institutes: Fujian Provincial Hospital, Urological Department, Fuzhou, China
-
Opening Ceremony
Opening Ceremony
-
Networking Reception
Networking Reception
-
-
Orange Area, eURO Auditorium 2
-
Game changer session
Game changer session
-
Plenary session 4 - Nightmare on robotics
Nightmare on robotics Plenary session 4
Nightmare on robotics
Plenary session 4
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives Bertie Leigh is back exploring and probing the complications of robotic surgery through the prism of the law court. In so doing we hope to improve approaches to consent, surgical technique and training.
Scenarios 1&3 explore challenges arising from the uniqueness of robotics viz, what to do after mechanical failure and issues arising from the physical separation of surgeon and assistant. Scenario 2 explores the transition to performing highly complex robotic procedures.
The session will be entertaining and challenging. “If my case came to court, how would I look?“
Case discussion Mechanical failure of the robot during RARP: Should I have stopped? Case solution and audience questions
Case discussion Were you ready for this level of complexity? Robotic T3 RCC into the IVC Case solution and audience questions
Case discussion Was your team appropriately skilled? Bowel perforation during robotic radical cystectomy Case solution and audience questions
Closing remarks
-
-
Plenary session 6 - Bladder dysfunction, storage symptoms and benign prostatic disease
Bladder dysfunction, storage symptoms and benign prostatic disease Plenary session 6
Bladder dysfunction, storage symptoms and benign prostatic disease
Plenary session 6
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives This plenary session on male LUTS will cover the topic of bladder dysfunction especially in the context of concomitant benign prostatic obstruction. Leaders in the field will comprehensively discuss up-to-date medical and surgical solutions, recent advances in the therapies of male LUTS and current key pathophysiological concepts underlying male LUTS.
Crossfire Non-neurogenic OAB in a 60yr man with 60g prostate: First-line medical prescription Choose a Beta-3 agonist To be confirmed
Crossfire Non-neurogenic OAB and proven obstuction, drugs don't work -
-
Plenary session 2 - #Testis cancer and surgical andrology
#Testis cancer and surgical andrology Plenary session 2
#Testis cancer and surgical andrology
Plenary session 2
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives After starting off this session with an update on the treatment algorithm of Peyronie’s disease and surgical aspects of genital reconstruction, the interrelationship of testicular cancer and male infertility –both arising from the testicular dysgenesis syndrome (TDS)- will be discussed. The attendee will take home a deeper insight in the molecular connection between these two diseases and the impact of one diagnosis on the management of the other. Autologous testicular tissue transplants are on the horizon and will be highlighted. MicroRNAs as biomarkers and robotic approaches of retroperitoneal masses are further topics of discussion and state-of-the art presentations will help to clarify their roles in current management.
Debate Twitter told me the robot can do it: Small retroperitoneal masses in testis cancer, what is best? Stage IIA -
-
Poster Session 01 - Translation potential of innovative therapies in urothelium cancer
Translation potential of innovative therapies in urothelium cancer Poster Session 01
Translation potential of innovative therapies in urothelium cancer
Poster Session 01
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives On the basis of improvement classification of urothelium cancer, personalized approaches in research are developed. This session will focus on immuno-, chemo- and targeted therapy in this tumor type.
* 1VAR2-armed CAR T-cells as an immunotherapeutic strategy for bladder cancer
By: Oo H.Z. 1 , Khazamipour N. 1 , Ardekani G. 1 , Roberts M. 1 , Al Nakouzi N. 1 , Gustavsson T. 2 , Fazli L. 1 , Salanti A. 2 , Black P. 1 , Daugaard M. 1
Institutes: 1Vancouver Prostate Centre, University of British Columbia, Dept. of Urologic Sciences, Vancouver, Canada, 2Centre for Medical Parasitology, University of Copenhagen, Dept. of Immunology and Microbiology, Copenhagen, Denmark
* 2The supplementary GM-CSF to neoadjuvant gemicitabine-cisplatin systemic chemotherapy plus PD-L1 blockade decrease local tumor recurrence of urothelial carcinoma after surgery via suppression of MDSCs in blood and tumor microevironment
By: Miyake M. , Hori S. , Nishimura N. , Owari T. , Itami Y. , Nakai Y. , Tanaka N. , Fujimoto K.
Institutes: Nara Medical University, Dept. of Urology, Nara, Japan
3Targeting myeloid-derived suppressor cells (MDSCs) with immune checkpoint inhibitors for treating cisplatin-resistant bladder cancer
By: Takeyama Y.T. , Kato M. , Tamada S. , Azuma Y. , Shimizu Y. , Iguchi T. , Yamasaki T. , Gi M. , Wanibuchi H. , Nakatani T.
Institutes: Osaka City University Graduate School of Medicine, Dept. of urology, Osaka, Japan
5Cis-platinum induces immunity evasion demonstrated by PD-L1 expression in bladder cancer cells
By: Hwang T. 1 , Chen P. 2 , Tsai T. 1 , Yang S. 2 , Chen H. 1 , Lin Y. 1 , Chou K. 1 , Lin J. 2
Institutes: 1Shin Kong WHS Memorial Hospital, Dept. of Urology, Taipei, Taiwan, 2Shin Kong WHS Memorial Hospital, Dept. of Central Laboratory, Taipei, Taiwan
6Semaphorin 3C knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes in bladder cancer
By: Takeuchi A. , Shiota M. , Inokuchi J. , Eto M.
Institutes: Graduate School of Medical Sciences, Kyushu University, Dept. of Urology, Fukuoka, Japan
7Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization and causes bladder cancer with p53 dysfunction
By: Kobatake K. 1 , Ikeda K. 1 , Nakata Y. 2 , Yamasaki N. 2 , Hayashi T. 1 , Sentani K. 3 , Yasui W. 3 , Kaminuma O. 2 , Horie S. 4 , Black P.C. 5 , Matsubara A. 1 , Honda H. 6
Institutes: 1Hiroshima University, Dept. of Urology, Hiroshima, Japan, 2Research Institute for Radiation Biology and Medicine, Hiroshima University, Dept. of Disease Model, Hiroshima, Japan, 3Hiroshima University, Dept. of Molecular Pathology, Hiroshima, Japan, 4Juntendo University, Dept. of Urology, Tokyo, Japan, 5University of British Columbia, Dept. of Urologic Sciences, Vancouver, Canada, 6Institute of Laboratory animals, Tokyo Women's Medical University, Dept. of Human Disease Model, Tokyo, Japan
8An internal cross-linked polymeric nanoparticle with dual sensitivity for combination therapy of muscle-invasive bladder cancer
By: Zhu G.C. 1 , Qin H.X. 1 , Zhao X.Z. 1 , Xu L.F. 1 , Chen W. 1 , Cao W.M. 1 , Wang K.K. 2 , Guo H.Q. 1
Institutes: 1Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Dept. of Urology, Nanjing, China, 2Nantong University, Dept. of Pharmacy, Nantong, China
9Effects of miR-30a-3p on autophagy and invasion in bladder cancer cell
By: Chou K-Y. 1 , Chen P-C. 2 , Ciou P-C. 2 , Tsai T-F. 1 , Chen H-E. 1 , Lin Y-C. 1 , Lin J-F. 2 , Hwang T.I. 1
Institutes: 1SHin Kong WHS Memorial Hopstial, Dept. of Urology, Taipei, Taiwan, 2SHin Kong WHS Memorial Hopstial, Central Laboratory, Taipei, Taiwan
10Vorinostat and Ixazomib cause bladder cancer apoptosis synergistically by inducing endoplasmic reticulum stress
By: Sato A. , Asano T. , Okubo K.
Institutes: National Defense Medical College, Dept. of Urology, Tokorozawa, Japan
11Simvastatin augments anticancer activity of romidepsin in bladder cancer cells by causing AMP-activated protein kinase activation and histone acetylation
By: Okubo K. , Asano T. , Sato A.
Institutes: National Defense Medical College, Dept. of Urology, Tokorozawa, Japan
12Ritonavir, a potent inhibitor of CYP3A4, enhances the anticancer effects of panobinostat in bladder cancer cells
By: Sato A. , Asano T. , Okubo K.
Institutes: National Defense Medical College, Dept. of Urology, Tokorozawa, Japan
-
-
Thematic session 11 - Female Stress Urinary Incontinence (SUI)
Female Stress Urinary Incontinence (SUI) Thematic session 11
Female Stress Urinary Incontinence (SUI)
Thematic session 11
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives This thematic session will shed light on recent controversies about the use of synthetic slings in female with stress urinary incontinence. Experts will provide a complete update about this topic, discuss surgical alternatives and comprehensively review the armamentarium for stress incontinence management in the context of intrinsic sphincter deficiency.
Midurethral tapes for stress incontinence: Blessing or ban? Conslusion
-
-
Joint meeting of the EAU Section of Oncological Urology (ESOU), the EAU Robotic Urology Section (ERUS), the EAU Section of Uro-Technology (ESUT) and with the ECCO, EORTC GUCG, ESMO, ESSO, ESTRO and EUOG - Common problems in onco-urology
Common problems in onco-urology Joint meeting of the EAU Section of Oncological Urology (ESOU), the EAU Robotic Urology Section (ERUS), the EAU Section of Uro-Technology (ESUT) and with the ECCO, EORTC GUCG, ESMO, ESSO, ESTRO and EUOG
Common problems in onco-urology
Joint meeting of the EAU Section of Oncological Urology (ESOU), the EAU Robotic Urology Section (ERUS), the EAU Section of Uro-Technology (ESUT) and with the ECCO, EORTC GUCG, ESMO, ESSO, ESTRO and EUOG
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:Moderators:
-
Learning objectives To promote the role of European urologists as principal caregivers in the field of Genito Urinary cancers.
To advance care across the spectrum of GU cancers.
To highlight scientific alliance between EAU sections and other scientific associations where borders between the roles of oncologists, radiotherapists and urologists are non-existent.
The European Uro-Oncology Group (EUOG) Discussion
The European Cancer Organisation (ECCO) Oncology outcomes in economic organisation: The QALY and utilities To be confirmed
Discussion
The European Society for Radiotherapy & Oncology (ESTRO) Discussion
The European Society for Medical Oncology (ESMO) Discussion
The European Organisation for Research and Treatment of Cancer Genito-Urinary Cancer Group (EORTC GUCG) Discussion
The European Society of Surgical Oncology (ESSO) Discussion
ESOU-ESUT-ERUS: Evidence-based case debates and controversies in onco-urology -
-
Specialty Session - European Urology - Treatment of small renal masses
Treatment of small renal masses Specialty Session - European Urology
Treatment of small renal masses
Specialty Session - European Urology
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives The Surgery-in-Motion session is dedicated to the latest treatment strategies in small renal masses. Experts in the field will provide explanations and video demonstrations of various surgical techniques and discuss why they do it “their way”. Questions from the audience are welcome.
Alternative management to surgery Discussion
Discussion
Discussion
RAPN step-by-step Discussion
Discussion
Discussion
Closing remarks
-
-
Poster Session 06 - Biomarkers in urothelium cancer and adjacent stroma
Biomarkers in urothelium cancer and adjacent stroma Poster Session 06
Biomarkers in urothelium cancer and adjacent stroma
Poster Session 06
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives Improving of knowledge on urothelium cancer biomarkers is particularly important because of proposed molecular classification. There is a large group of potential biomarkers and advantages and potential disadvantages of their use will be discussed in the session.
* 66Impact of molecular subtyping and immune infiltration on response and outcome following neoadjuvant pembrolizumab (pembro), versus neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer
By: Necchi A. 1 , Raggi D. 1 , Briganti A. 2 , Farè E. 1 , Giannatempo P. 1 , Marandino L. 1 , Gallina A. 2 , Colecchia M. 1 , Lucianò R. 2 , Bianchi M. 2 , Colombo R. 2 , Salonia A. 2 , Gandaglia G. 2 , Fossati N. 2 , Capitanio U. 2 , Montorsi F. 2 , Boormans J. 3 , Liu Y. 4 , De Jong J. 3 , Dittamore R. 4 , Davicioni E. 4 , Black P. 5 , Gibb E. 4
Institutes: 1Fondazione IRCCS Istituto Nazionale dei Tumori, Dept. of Medical Oncology, Milan, Italy, 2IRCCS San Raffaele Hospital, Dept. of Urology, Milan, Italy, 3Erasmus MC Cancer Institute, Dept. of Urology, Rotterdam, The Netherlands, 4Decipher Biosciences, Decipher Biosciences, Vancouver, Canada, 5University of British Columbia, Dept. of Urology, Vancouver, Canada
67Withdrawn
* 68The role of adipocytokines and their receptors in bladder cancer: Expression of adiponectin or leptin is an independent prognosticator
By: Kashiwagi E. 1 , Abe T. 1 , Ushijima M. 1 , Shiota M. 1 , Netto G. 2 , Eto M. 1 , Miyamoto H. 3
Institutes: 1Kyushu University, Dept. of Urology, Fukuoka, Japan, 2Johns Hopkins University, Dept. of Pathology, Baltimore, United States of America, 3University of Rochester Medical Center, Depts. of Pathology & Laboratory Medicine, Rochester, United States of America
69Impact of neoadjuvant chemotherapy on Ki67 proliferation index and PDL1 expression in muscle-invasive bladder cancer
By: Horiguchi H. , Hatakeyama S. , Hashimoto Y. , Yoneyama T. , Yamamoto H. , Imai A. , Ohyama C.
Institutes: Hirosaki University Graduate School of Medicine, Dept. of Urology, Hirosaki, Japan
70SERPINB2 expression in bladder cancer is associated with cancer stem-cell like properties
By: Hiraki M. , Ogawa K. , Kishi H. , Yasumoto H. , Shiina H.
Institutes: Shimane University Faculty of Medicine, Dept. of Urology, Izumo, Japan
71Prediction of metastatic relapse and therapeutic response in muscle-invasive bladder cancer patients by liquid biopsy
By: Carrasco R. 1 , Izquierdo L. 2 , Ingelmo-Torres M. 2 , Roldan F. 2 , Gomez A. 2 , Alcaraz A. 2 , Mengual L. 2
Institutes: 1Hospital Clinic, Dept. of Laboratory of Urology, Barcelona, Spain, 2Hospital Clinic, IDIBAPS, Universitat de Barcelona, Dept. of Laboratory of Urology, Barcelona, Spain
* 72Identifying changes in the tumor micro-environment in muscle-invasive bladder cancer after neo-adjuvant chemotherapy
By: van Dorp J. 1 , Gil Jimenez A. 1 , Voskuilen C.S. 2 , Van Rhijn B.W.G. 2 , Van Der Heijden M.S. 1
Institutes: 1Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Dept. of Molecular Carcinogenesis, Amsterdam, The Netherlands, 2Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Dept. of Urology, Amsterdam, The Netherlands
73Concordance of plasmatic circulating DNA and matched metastatic tissue in metastatic urothelial carcinoma
By: Duquesne I. 1 , Menssouri N. 1 , Pata-Merci N. 1 , Tang R. 2 , Ngo-Camus M. 3 , Nicotra C. 3 , Scoazec J.Y. 2 , Massard C. 3 , Besse B. 4 , Rouleau E. 2 , Loriot Y. 4
Institutes: 1Institut Gustave Roussy, Research Department (U981), Villejuif, France, 2Institut Gustave Roussy, Dept. of Medical Biology and Pathology, Villejuif, France, 3Institut Gustave Roussy, Drug Development Department (DITEP), Villejuif, France, 4Institut Gustave Roussy, Medical Oncology, Villejuif, France
74Identifying immune-related biomarkers to predict clinical outcomes of neoadjuvant immuno-chemotherapy (nivolumab, gemcitabine and cisplatin) in muscle-invasive bladder cancer (NCT03294304)
By: Eckstein M. 1 , Konety B. 2 , Weight C. 2 , Sonpavde G. 3 , Gupta S. 4 , Maughan B. 4 , Gibb E. 5 , Davicioni E. 5 , Paari M. 6 , Thyagarajan B. 6 , Neeraj A. 4 , Gupta S. 7
Institutes: 1Friedrich-Alexander-Universität Erlangen-Nürnberg, Institute of Pathology, Erlangen, Germany, 2University of Minnesota, Dept. of Urology, Minneapolis, United States of America, 3Harvard Medical School, Dana-Farber Cancer Institute, Boston, United States of America, 4University of Utah, Huntsman Cancer Institute, Salt Lake City, United States of America, 5GenomeDX Biosciences, Bladder Cancer Field, Vancouver, Canada, 6University of Minnesota, Dept. of Lab Medicine and Pathology, Minneapolis, United States of America, 7Cleveland Clinic, Taussig Cancer Institute, Cleveland, United States of America
75Amplification of 7p12 is associated with pathologic non-response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
By: Pichler R. 1 , Lindner A.K. 1 , Compérat E. 2 , Obrist P. 3 , Schäfer G. 4 , Todenhöfer T. 5 , Horninger W. 1 , Zoran C. 1 , Untergasser G. 6
Institutes: 1Medical University Innsbruck, Dept. of Urology and Andrology, Innsbruck, Austria, 2Sorbonne University, Dept. of Anatomie-Pathologique Hôpital Tenon HUEP, Paris, France, 3Pathology Laboratory Obrist and Brunhuber, Dept. of Pathology, Zams, Austria, 4Medical University Innsbruck, Dept. of Pathology, Innsbruck, Austria, 5Eberhard Karls University, Dept. of Urology, Tübingen, Germany, 6Medical University Innsbruck, Dept. of Internal Medicine V, Innsbruck, Austria
76Exosomal transfer of HNRNPL promotes normal fibroblasts to cancer-associated fibroblasts transition in bladder cancer
By: Chen C. , Hao H , Guangzheng Z. , Xu C. , Tianxin L.
Institutes: Sun Yat-sen Memorial Hospital, Dept. of Urology, Guangzhou, China
1055Bladder cancer cell proliferation is inhibited by radiofrequency treatment alone and combined with hyperthermia and chemotherapeutic agents in vitro
By: Brummelhuis I.S.G. 1 , Lev G.M. 2 , Van Hattum J.W. 3 , Witjes J.A. 1 , Oosterwijk E. 1
Institutes: 1Radboud UMC, Dept. of Urology, Nijmegen, The Netherlands, 2Medical Enterprises Group, Dept. of Urology, Amstelveen, The Netherlands, 3Amsterdam UMC, Dept. of Urology, Amsterdam, The Netherlands
1146Combination of platelet and neutrophil to lymphocyte ratio as an independent factor for overall and cancer specific survival after radical cystectomy. A multicentric retrospective cohort
By: Sánchez Pérez M. 1 , Jiménez Marrero P. 1 , Amador Robayna A. 2 , Hernández Escobar S. 1 , Espino Espino R. 1 , Moreno Guerra L. 1 , Marrero Domínguez R. 1
Institutes: 1Hospital Universitario de Gran Canaria Dr. Negrín, Dept. of Urology, Las Palmas de Gran Canaria, Spain, 2Hospital Universitario Nuestra Señora de Candelaria, Dept. of Urology, Santa Cruz de Tenerife, Spain
-
-
Poster Session 60 - Surgical BPO relief: All about enucleation
Surgical BPO relief: All about enucleation Poster Session 60
Surgical BPO relief: All about enucleation
Poster Session 60
820Randomized trial of bipolar resection vs. Holmium laser enucleation vs. Greenlight laser vapo-enucleation of the prostate for treatment of large sized benign prostate obstruction; 3-years outcome
By: Elshal A. 1 , Soltan M.A. 1 , Laymon M.N. 1 , El-Tabey N. 1 , Nabeeh H. 2 , Nabeeh A. 1
Institutes: 1Mansoura Urology and Nephrology Center, Dept. of Urology, Mansoura, Egypt, 2Kafr El-Shiekh university, Dept. of Urology, Kafr El Sheikh, Egypt
821A prospective randomized study compares the safety and efficacy of Holmium laser enucleation of prostate versus bipolar transuretheral resection of prostate for management of benign prostatic enlargement
By: Hassan A.A. 1 , Mamdouh M.H. 1 , Elbendary A.E. 1 , Habib E. 2
Institutes: 1Tanat University, Dept. of Urology, Tanta, Egypt, 2Cairo University, Dept. of Urology, Cairo, Egypt
822Do postoperative benefits continue after 10 years from Holmium Laser Enucleation of the Prostate (HoLEP)?
By: Fallara G. 1 , Capogrosso P. 1 , Candela L. 1 , Schifano N. 1 , Pellegrino F. 1 , Cazzaniga W. 1 , Boeri L. 2 , Belladelli F. 1 , Dehò F. 1 , Matloob R. 1 , Mirone V. 3 , Salonia A. 1 , Montorsi F. 1
Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2IRCCS Fondazione Ca’ Granda – Ospedale Maggiore Policlinico, University of Milan, Dept. of Urology, Milan, Italy, 3Università Federico II, Dept. of Urology, Naples, Italy
823The effect of laser energy consumption on the lower urinary tract symptoms in early stage after hoLEP
By: Liu K. , Xiao C. , Ma L.
Institutes: Peking University Third Hospital, Dept. of Urology, Beijing, China
825Anterior prostatic urethral mucosa preservation technique in one-lobe enucleation HoLEP has a potential to reduce post-surgical incontinence
By: Fujisaki Y. 1 , Kobayashi T. 2 , Miyake N. 2 , Ito K. 2 , Terada N. 1 , Kamoto T. 1 , Iwamoto H. 2
Institutes: 1Faculty of Medicine, University of Miyazaki Hospital, Dept. of Urology, Miyazaki, Japan, 2Nozaki higashi Hospital, Dept. of Urology, Miyazaki, Japan
826The novel HoLEP technique Omega Sign improves continence outcomes of surgery
By: Tunc L. 1 , Yalcin S. 2 , Kaya E. 2 , Gazel E. 3 , Yilmaz S. 2 , Aybal H.C. 4 , Yilmaz M. 5 , Tokas T. 6
Institutes: 1Gazi University School of Medicine, Dept. of Urology, Ankara, Turkey, 2Health Sciences University,Gülhane Training and Research Hospital, Dept. of Urology, Ankara, Turkey, 3Acıbadem University Ankara Hospital, Dept. of Urology, Ankara, Turkey, 4Health Sciences University, Dr.Abdurrahman Yurtaslan Oncology Training and Research Hospital, Dept. of Urology, Ankara, Turkey, 5Health Sciences University Ankara City Hospital, Dept. of Urology, Ankara, Turkey, 6General Hospital Hall i.T, Dept. of Urology and Andrology, Hall in Tirol, Austria
* 827Recovery from transient urinary incontinence post-HoLEP – findings from a prospective trial (ExpHo)
By: Capogrosso P. 1 , Schifano N. 1 , Pellegrino F. 1 , Candela L. 1 , Fallara G. 1 , Sorce G. 1 , Cazzaniga W. 1 , Matloob R. 1 , Boeri L. 2 , Deho' F. 1 , Abate C. 1 , Mirone V 3 , Salonia A. 1 , Montorsi F. 1
Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2IRCCS Fondazione Ca’ Granda – Ospedale Maggiore Policlinico, University of Milan, Dept. of Urology, Milan, Italy, 3University , Dept. of Urology, Naples, Italy
828Does 5-alpha reductase inhibitor intake impact procedural efficacy, short- and long- term functional outcomes in patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP)? - a retrospective single-center analysis among 1,360 patients
By: Gild P. 1 , Pompe R.S. 1 , Vetterlein M.W. 1 , Ludwig T.A. 1 , Soave A. 1 , Maurer V. 1 , Marks P. 1 , Becker A. 2 , Dahlem R. 1 , Fisch M. 1 , Rink M. 1 , Meyer C.P. 1
Institutes: 1University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 2University Medical Center Frankfurt and University Medical Center Hamburg-Eppendorf, Dept. of Urology, Frankfurt, Germany
829Does anaesthetic technique (spinal block vs. general anesthesia) impact procedural efficacy and functional outcomes in patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP)? A retrospective single-center analysis among 1,159 patients
By: Gild P. 1 , Yu H. 1 , Vetterlein M.W. 1 , Pompe R.S. 1 , Soave A. 1 , Ludwig T.A. 1 , Becker A. 2 , Maurer V. 1 , Marks P. 1 , Dahlem R. 1 , Fisch M. 1 , Meyer C.P. 1
Institutes: 1University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 2University Medical Center Frankfurt and University Medical Center Hamburg-Eppendorf, Dept. of Urology, Frankfurt, Germany
830HoLEP in men with catheter dependent urinary retention: Does early surgical intervention result in better outcomes?
By: Thakare N. , Maw J. , Stewart G.D. , Aho T.
Institutes: Cambridge University Hospitals NHS Foundation Trust, Dept. of Urology, Cambridge, United Kingdom
831A prospective, randomizised clinical trial comparing holmium laser enucleation versus photoselective vaporization for day-surgery to treat benign prostatehyperplasia
By: Chen Y.B. , Chen Q. , Gu M. , Liu C. , Wang Z.
Institutes: Shanghai Ninth People's Hospital, Dept. of Urology, Shanghai, China
832Evolution of day-case HoLEP success rate over time
By: Klein C 1 , Marquette T. 2 , Alezra E. 2 , Capon G. 2 , Bladou F. 2 , Ferriere J.M. 2 , Bensadoun H. 2 , Bernhard J.C. 2 , Robert G. 2
Institutes: 1Chu Pellegrin , Dept. of Urology, Bordeaux, France, 2Chu Pellegrin, Dept. of Urology, Bordeaux, France
833Definition of a structured training curriculum for holmium laser enucleation of the prostate
By: Dell'Oglio P. 1 , Goossens M. 2 , Montorsi F. 3 , Aho T. 4 , Kuenen M. 5 , Broglia L. 3 , Vavassori I. 6 , Misraï V. 7 , Miernik A. 8 , Stragier J. 9 , Rappe B. 10 , Roche J. 11 , Kuntz R. 12 , Robert G. 13 , Baumert H. 14 , Gilling P. 15 , Scattoni V. 16 , Scoffone C.M. 17 , Ahyai S. 18 , Hermann T. 19 , Gomez-Sancha F. 20 , Chun F. 21 , Lehrich K. 22 , De Naeyer G. 2 , Schatteman P. 2
Institutes: 1ORSI Academy; Onze Lieve Vrouw Hospital;, Dept. of Urology, Aalst, Belgium, 2Onze Lieve Vrouw Hospital, Dept. of Urology, Aalst, Belgium, 3San Raffaele Hospital, Dept. of Urology, Milan, Italy, 4Addenbrooke's Hospital, Cambridge University Hospitals, Dept. of Urology, Cambridge, United Kingdom, 5Zuyderland Ziekenhuis, Dept. of Urology, Heerlen, The Netherlands, 6Ospedale di Treviglio, Dept. of Urology, Bergamo, Italy, 7Clinique Pasteur, Dept. of Urology, Toulouse, France, 8University of Freiburg-Medical Centre, Dept. of Urology, Freiburg, Germany, 9St Franciscus Ziekenhuis, Dept. of Urology, Heusden-Zolder, Belgium, 10Algemeen Stedelijk Ziekenhuis, Dept. of Urology, Aalst, Belgium, 11Clinique Saint Augustin, Dept. of Urology, Bordeaux, France, 12Auguste-Viktoria-Hospital, Dept. of Urology, Berlin, Germany, 13CHU de Bordeaux, Service d'urologie Andrologie et Transplantation Rénale, Université de Bordeaux, Dept. of Urology, Bordeaux, France, 14Saint-Joseph Hospital, Dept. of Urology, Paris, France, 15Tauranga Urology Research, Dept. of Urology, Tauranga, New Zealand, 16San Raffaele Hospital, Dept. of Urology, Milano, Italy, 17Cottolengo Hospital, Dept. of Urology, Torino, Italy, 18University Medical Center Göttingen, Dept. of Urology, Göttingen, Germany, 19Hanover Medical School (MHH), Dept. of Urology, Hanover, Germany, 20ICUA-Clínica Cemtro, Dept. of Urology, Madrid, Spain, 21University Clinic Frankfurt, Dept. of Urology, Frankfurt, Germany, 22Auguste Viktoria Hospital, Dept. of Urology, Berlin, Germany
-
Special session - Controversies in Bladder Cancer 2020: Rapid fire debates
Controversies in Bladder Cancer 2020: Rapid fire debates Special session
Controversies in Bladder Cancer 2020: Rapid fire debates
Special session
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives - Using case based discussions, allow the presenters an opportunity to discuss nuances of common dilemmas facing urologic oncology patients and providers
- Use evidence based debates to provide clear, rationale guidance on the management of difficult situations in bladder cancer
Rapid fire debate: Patients with NMIBC need lifelong follow-up Questions and answers
Rapid fire debate: Elderly patient with recurrent TaLG tumors, small size, negative cytology Questions and answers
Rapid fire debate: Ileal conduit or continent diversion; which is a better choice for patient with GFR ~ 60 Questions and answers
Rapid fire debate: Patient with pure UC, T2 disease, PDL1-high, GFR 54; seeking radical cystectomy. What is best option prior to radical cystectomy? Questions and answers
Rapid fire debate: Otherwise healthy patient with T1HG disease plus CIS; what is the best treatment? Questions and answers
Rapid fire debate: Optimal therapy for patient with T2 disease, located at dome of bladder after neoadjuvant chemotherapy Questions and answers
Rapid fire Debate: Otherwise healthy patient scheduled for radical cystectomy, what will have greater impact on recovery after radical cystectomy? Questions and answers
Rapid fire debate: 52 yr old female patient, with partial response in retroperitoneal lymph nodes after 6 cycles of platinum based chemotherapy Questions and answers
-
-
Poster Session 70 - Non-neurogenic voiding dysfunction: Better understanding for better treatment
Non-neurogenic voiding dysfunction: Better understanding for better treatment Poster Session 70
Non-neurogenic voiding dysfunction: Better understanding for better treatment
Poster Session 70
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives This session covers the issue of investigations needed to sort out underactive bladder and obstruction, as well as clinical and therapeutic aspects of voiding dysfunction.
967What are useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms?
By: Matsukawa Y. , Majima T. , Funahashi Y. , Ishida S. , Naito Y. , Kato M. , Yamamoto T. , Gotoh M.
Institutes: Nagoya University Graduate School of Medicine, Dept. of Urology, Nagoya, Japan
968How do we diagnose detrusor underactivity? The potential of parameters calculated with Watts factor
By: Kitta T. , Chiba H.C. , Higuchi M.H. , Ouchi M.O. , Togo M.T. , Takahashi Y.T. , Shinohara N.
Institutes: Hokkaido University, Dept. of Urology, Sapporo, Japan
969Should detrusor under activity preclude the decision of a prostatic de-obstructive surgery in men with chronic urinary retention?
By: Pedrosa Do Vale L. 1 , Antunes-Lopes T. 1 , Silva J. 1 , Martins-Silva C. 1 , Dinis P. 1 , Charrua A. 2 , Cruz F. 1
Institutes: 1Centro Hospitalar Universitário São João, Dept. of Urology, Porto, Portugal, 2University of Porto, Faculty of Medicine, Porto, Portugal
970Assessment of Bladder Contractility in Patients with Benign Prostate Hyperplasia using Invasive and Non Invasive Urodynamics
By: Bakr R. , Morsy S.S. , Abdel Azim M.S. , Hussein H.A.
Institutes: Cairo University, Dept. of Urology, Cairo, Egypt
971Bladder neck sparing surgery for male LUTD or not? Subtyping of bladder outflow obstruction
By: Rosier P.
Institutes: University Medical Center Utrecht, Dept. of Urology, Utrecht, The Netherlands
972Successful trial without catheter development of a clinical nomogram
By: De Nunzio C. 1 , Tema G. 1 , Cindolo L. 2 , Bada M. 2 , Lombardo R. 1 , Nacchia A. 1 , Cancrini F. 1 , Voglino O.A. 1 , Mancini E. 1 , Guarnotta G. 1 , Schips L. 3 , Gacci M. 4 , Milanesi M. 4 , Cito G. 4 , Serni S. 4 , Tubaro A. 1
Institutes: 1Sant'Andrea Hospital, Dept. of Urology, Rome, Italy, 2S. Pio da Pietrelcina Hospital, Dept. of Urology, Vasto, Italy, 3S. Pio Hospital da Pietrelcina, Dept. of Urology, Vasto, Italy, 4Careggi Hospital, Dept. of Urology, Florence, Italy
973Voiding dysfunction and sacral nerve stimulation in men: A ten year follow up review
By: Jenks J. , Paras J. , Ockrim J.L , Greenwell T.J , Pakzad M.H , Hamid R.
Institutes: University College London Hospitals NHS Trust, Dept. of Urology, London, United Kingdom
974Sacral neuromodulation and non-obstructive retention: Monocentric retrospective study
By: Auble A. 1 , Baron M. 1 , Chebbi A. 1 , Surlemont L. 1 , Leroi A.M. 2 , Cornu J.N. 1
Institutes: 1Rouen University Hospital, Dept. of Urology, Rouen, France, 2Rouen University Hospital, Dept. of Physiology, Rouen, France
975Third sacral foramen morphometry analysis in Chinese and lead implantation for sacral neuromodulation
By: Huang H. , Huang H. , Zeng W. , Fan F.
Institutes: Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Dept. of Urology, Guangzhou, China
976Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A retrospective, multicentre study in China
By: Meng L. 1 , Wei Z. 1 , Jianye W. 1 , Yaoguang Z. 1 , Peng Z. 2 , Limin L. 3 , Jianwei L. 4 , Qing L. 5 , Zhongqing W. 6 , Tie Z. 7 , Zhihui X. 8 , Wen W. 9 , Jiayi L. 4 , Deyi L. 10
Institutes: 1Beijing Hospital, Dept. of Urology, Beijing, China, 2Beijing Chaoyang Hospital, Dept. of Urology, Beijing, China, 3China Rehabilitation Research Centre, Dept. of Urology, Beijing, China, 4Renji Hospital, Shanghai Jiao Tong University School of Medicine, Dept. of Urology, Shanghai, China, 5Tongji Hospital, Huazhong University of Science and Technology, Dept. of Urology, Wuhan, China, 6The Second Affiliated Hospital of Nanjing Medical University, Dept. of Urology, Nanjing, China, 7The Second Affiliated Hospital of Xi’an Jiaotong University, Dept. of Urology, Xi'an, China, 8Zhejiang Provincial People’s Hospital, Dept. of Urology, Hangzhou, China, 9Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Dept. of Urology, Shanghai, China, 10West China Hospital, Sichuan University, Dept. of Urology, Chengdu, China
977Cardio-thoracic ratio (CTR) is associated with severe nocturia in men
By: Ito M. , Lida N. , Nakanishi Y. , Kataoka M. , Takemura K. , Suzuki H. , Fuse H. , Tobisu K. , Koga F.
Institutes: Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Dept. of Urology, Tokyo, Japan
978Association between male nocturia and smoking exposure: Does smoking cessation improve nocturia?
By: Iida N. , Ito M. , Nakanishi Y. , Kataoka M. , Takemura K. , Suzuki H. , Fuse H. , Tobisu K. , Koga F.
Institutes: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Dept. of Urology, Tokyo, Japan
979Nocturnal hesitancy is a bothersome symptom we cannot ignore
By: Tsang W.C. , Lata R. , Consigliere D. , Chiong E.
Institutes: National University Hospital, Dept. of Urology, Singapore, Singapore
980Post micturition dribble is a highly bothersome urinary symptom: Sub analysis from the urodynamics for prostate surgery trial; randomised evaluation of assessment methods (upstream) study
By: Ito H. 1 , Young G.J. 2 , Lewis A.L. 2 , Blair P. 3 , Cotterill N. 3 , Abrams P. 3 , Lane A. 2 , Drake M.J. 3
Institutes: 1Yokosuka Kyosai Hospital, Dept. of Urology, Kanagawa, Japan, 2University of Bristol, Population Health Sciences, Bristol, United Kingdom, 3Southmead Hospital, Bristol Urological Institute, Bristol, United Kingdom
981Withdrawn
-
-
Poster Session 79 - Female urology miscellaneous
Female urology miscellaneous Poster Session 79
Female urology miscellaneous
Poster Session 79
1078Complications after perineal surgery (with or without implantation of material): First results of the French multicenter observatory VIGIMESH after 1873 inclusions
By: Charles T. 1 , Campagne-Loiseau S. 2 , Cosson M. 3 , Ferry P. 4 , Saussine C. 5 , Lucot J.-P. 6 , Salet-Lizee D. 7 , Barussaud M.-L. 8 , Boisramé T. 9 , Carlier-Guérin C. 10 , Debodinance P. 11 , Deffieux X. 12 , Pizzoferrato A.-C. 13 , Curinier S. 2 , Ragot S. 14 , Ringa V. 15 , De Tayrac R. 16 , Fauconnier A. 17 , Fritel X. 18
Institutes: 1CHU de Poitiers, Dept. of Urology, Poitiers, France, 2CHU Estaing, Dept. of Gynaecology and Obstetrics, Clermont-Ferrand, France, 3Université de Lille, Dept. of Gynaecology and Obstetrics, Lille, France, 4CH de La Rochelle, Dept. of Gynaecology and Obstetrics, La Rochelle, France, 5Université de Strasbourg, Dept. of Urology, Strasbourg, France, 6Hôpital Saint-Vincent-de-Paul, Dept. of Gynaecology and Obstetrics, Lille, France, 7Groupe Hospitalier Diaconesses-Croix-Saint-Simon, Dept. of Gynaecology, Paris, France, 8CHU de Poitiers, Dept. of Visceral Surgery , Poitiers, France, 9CHU de Strasbourg, Dept. of Gynaecology and Obstetrics, Strasbourg, France, 10CHU de Poitiers, Dept. of Gynaecology and Obstetrics, Poitiers, France, 11CH de Dunkerque, Dept. of Gynaecology and Obstetrics, Dunkirk, France, 12Université Paris-Sud, Dept. of Gynaecology and Obstetrics, Paris, France, 13CHU de Caen, Dept. of Gynaecology and Obstetrics, Caen, France, 14Université de Poitiers, Clinical Investigation Center, Poitiers, France, 15Université de Poitiers, Inserm U1018, Poitiers, France, 16Université de Nimes, Dept. of Gynaecology and Obstetrics, Nîmes, France, 17Université de Versailles Saint-Quentin-en-Yvelines, Dept. of Gynaecology and Obstetrics, Poissy, France, 18Université de Poitiers, Dept. of Gynaecology and Obstetrics, Poitiers, France
1080Total versus subtotal hysterectomy associated with laparoscopic colposacropexy: A prospective randomized controlled trial
By: Illiano E. 1 , Natale F. 2 , Marchesi A. 3 , Zucchi A. 1 , Motta G. 4 , Costantini E. 5
Institutes: 1University of Perugia, Andrological and Urogynecological Clinic, Santa Maria Terni Hospital, Terni, Italy, 2San Carlo Nancy Hospital, Urogynecological Unit, Rome, Italy, 3University of Perugia, Andrological and Urogynecological Clinic,Santa Maria Terni Hospital, Terni, Italy, 4University of Milan, San Donato Hospital, Dept. of Urology, Milan, Italy, 5University of Perugia, Terni, Italy
1081Sexual dysfunction in adult women with spina bifida
By: Richard C. 1 , Voiry C. 2 , Freton L. 1 , Kerdraon J. 3 , Hascoet J. 1 , Brochard C. 4 , Bonan I. 2 , Jezequel M. 5 , Siproudhis L. 4 , Manunta A. 1 , Peyronnet B. 1
Institutes: 1Univeritary hospital of Rennes, Dept. of Urology, Rennes, France, 2Univeritary hospital of Rennes, Dept. of Physical medicine and rehabilitation, Rennes, France, 3Univeritary hospital of Rennes, Dept. of physical medicine and rehabilitation, Rennes, France, 4Univeritary hospital of Rennes, Dept. of Gastro-enterology, Rennes, France, 5Univeritary hospital of Rennes, National spina bifida center, Rennes, France
1082Sexual function outcomes in patients and patients’ spouses after midurethral sling procedure for stress urinary incontinence: Data from a minimum of 6 years of follow-up
By: Song P.H. , Kim Y.U. , Choi J.Y. , Ko Y.H. , Moon K.H. , Jung H.C.
Institutes: College of Medicine, Yeungnam University, Dept. of Urology, Daegu, South Korea
1083Surgeon tailored transobturator four arms mesh versus anterior colporrhaphy in the surgical management of cystocele accompanied by stress urinary incontinence
By: Shaher H.Shaher , Soliman Othman T.
Institutes: Benha faculty of medicine, Dept. of Urology, Benha, Egypt
1084Excision of symptomatic female urethral diverticulae: Outcomes in 121 cases utilising a modified prone jackknife position
By: Osman N.I. , Franco A. , Ricci E. , Mangir N. , Inman R.D. , Chapple C.R.
Institutes: Royal Hallamshire Hospital, Dept. of Urology, Sheffield, United Kingdom
1085In vitro study of cellular, molecular and functional mechanisms underlying pelvic floor disorders
By: Medina-Polo J. 1 , Flores A.I. 2 , Perez-Lorenzo M.J. 2 , Alcazar-Garrido A. 2 , De La Torre P. 2 , García-García-Porrero A. 3 , Gutiérrez-Vélez M.C. 3 , Delapuente-Ovejero L. 4 , García-Muñoz H. 1 , Grande-García J. 3 , Muñoz-Gálligo E. 3
Institutes: 1Hospital 12 de Octubre, Dept. of Urology, Madrid, Spain, 2Instituto de Investigación, Hospital 12 de Octubre, Research Center, Madrid, Spain, 3Hospital 12 de Octubre, Dept. of Gynecology , Madrid, Spain, 4Instituto de Investigación, Hospital 12 de Octubre2 DE OCTUBRE, Research Center, Madrid, Spain
1086Is the H line better than current reference lines for classifying anterior pelvic prolapse on magnetic resonance imaging?
By: Rechi Sierra K. , Garcia Ibañez J. , Sánchez Ballester F. , Monzó Cataluña A. , Mitjana Biosca S. , Diranzo Garcia M. , Beltrán Puig M. , Juan Escudero J.U. , Povo Martín I.J. , Pardo Duarte P. , López Alzina E.
Institutes: General University Hospital of Valencia, Dept. of Urology, Valencia, Spain
1087Patient factors affect radiation exposure during video urodynamics
By: Yasmin H. , Toia B. , Axell R. , Aleksejeva K. , Pakzad M. , Hamid R. , Ockrim J. , Greenwell T.
Institutes: University College Hospital London NHS Foundation Trust, Dept. of FFR Urology, London, United Kingdom
1088Urethral pressure profile in women with voiding dysfunction – reproducibility and inter-observer error
By: Toia B. , Axell R. , Yasmin H. , Pakzad M. , Hamid R. , Greenwell T. , Ockrim J.
Institutes: University College London Hospitals NHS Trust, Dept. of Urology, London, United Kingdom
1089Are there differences in the urodynamic findings after laparoscopic sacrocolpopexy and Trocarless Transvaginal Mesh System for symptomatic pelvic organ prolapse?
By: Illiano E. 1 , Natale F. 2 , Motta G. 3 , Rubilotta E. 4 , Balzarro M. 4 , Costantini E. 1
Institutes: 1University of Perugia, Santa Maria Terni Hospital, Andrological and Urogynecological Clinic, Terni, Italy, 2San Carlo Nancy Hospital, Urogynecological Unit, Rome, Italy, 3University of Milan, San Donato Hospital, Urology Clinic, Milan, Italy, 4University of Verona, Dept. of Urology, Verona, Italy
1090Large anesthetic bladder capacity is predictive of better response to hydrodistention in interstitial cystitis/bladder pain syndrome
By: Tsai C. , Fan Y. , Lin A.T.L. , Huang W.J.
Institutes: Taipei Veterans General Hospital, Dept. of Urology, Taipei, Taiwan
1091Does videourodynamic diagnosis of primary bladder neck obstruction in women predict success after bladder neck incision independent of detrusor pressure?
By: Peyronnet B. , Sussman R. , Palmerola R. , Escobar C. , Pape D. , Rosenblum N. , Brucker B. , Nitti V.
Institutes: New York University, Dept. of Urology, New York, United States of America
1092Analysis of the correlation between the clinical effect of sacral neuromodulation and patients’ age — a retrospective, multicenter study in China
By: Meng L. 1 , Wei Z. 1 , Yaoguang Z. 1 , Jianye W. 1 , Limin L. 2 , Guoqing C. 2 , Ling Q. 3 , Peng Z. 4 , Zhongqing W. 5 , Qi C. 6
Institutes: 1Beijing Hospital, Dept. of Urology, Beijing, China, 2China Rehabilitation Research Centre, Dept. of Urology, Beijing, China, 3Tongji Hospital, Huazhong University of Science and Technology, Dept. of Urology, Wuhan, China, 4Beijing Chaoyang Hospital, Dept. of Urology, Beijing, China, 5The Second Affiliated Hospital of Nanjing Medical University, Dept. of Urology, Nanjing, China, 6The Second Affiliated Hospital of Xi’an Jiaotong University, Dept. of Urology, Xi'an, China
-
Poster Session 26 - Potential new techniques for the treatment of localised prostate cancer
Potential new techniques for the treatment of localised prostate cancer Poster Session 26
Potential new techniques for the treatment of localised prostate cancer
Poster Session 26
-
Location:Orange Area, eURO Auditorium 2
-
Chairs:
-
Learning objectives New technologies are emerging, especially in the field of surgery. Moreover, ways to manage and to evaluate prostate cancer patients are also constantly changing. This session takes a peek on what might be the standard in the near future.
342Benchmarking radical prostatectomy – analysis of the British Association of Urological Surgeons national database for radical prostatectomy
By: John J.B. 1 , Pascoe J. 1 , Fowler S. 2 , Walton T.J. 3 , Johnson M.I. 4 , Aning J. 5 , Challacombe B.J. 6 , Mcgrath J.S. 1 , on behalf of the BAUS Section of Oncology
Institutes: 1Royal Devon and Exeter NHS Foundation Trust, Dept. of Urology, Exeter, United Kingdom, 2British Association of Urological Surgeons, Dept. of Research and Audit, London, United Kingdom, 3Nottingham University Hospitals NHS Trust, Dept. of Urology, Nottingham, United Kingdom, 4The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Dept. of Urology, Newcastle, United Kingdom, 5North Bristol NHS Trust, Dept. of Urology, Bristol, United Kingdom, 6Guy's and Thomas' NHS Foundation Trust, Dept. of Urology, London, United Kingdom
343Ten years of experience in robot-assisted laparoscopic radical prostatectomy in brazil: Indirect evaluation of the perioperative costs and oncologic patients’ profiles
By: Amaral B. 1 , Carneiro A. 1 , Budib Lourenço D. 1 , Langer Wroclawski M. 1 , Camargo Tiseo B. 1 , Alfer Junior W. 1 , Roberto Colombo J. 1 , Vasconcelos A. 2 , Russo F. 2 , Jim Kim N. 2 , Eduardo Alonso Araujo S. 2 , Cendoroglo Neto M. 2 , Caserta Lemos G. 1
Institutes: 1Hospital Israelita Albert Einstein, Dept. of Urology, Sao Paulo, Brazil, 2Hospital Israelita Albert Einstein, Dept. of Robotic Surgery, Sao Paulo, Brazil
344Comparison of learning curves with Da Vinci Standard/Si/Xi and Single Port robotic platform during radical prostatectomy: A single surgeon experience
By: Francavilla S. 1 , Veccia A. 2 , Zattoni F. 3 , Vigneswaran H.T. 1 , Talamini S. 1 , Antonelli A. 4 , Simeone C. 2 , Dal Moro F. 3 , Crivellaro S. 1
Institutes: 1University of Illinois, Dept. of Urology, Chicago, United States of America, 2University of Brescia, ASST Spedali Civili Hospital, Dept. of Urology, Brescia, Italy, 3University of Udine, Dept. of Urology, Udine, Italy, 4University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Dept. of Urology, Verona, Italy
345Comparison of Outcomes Between Single-Port and Standard Robot-Assisted Radical Prostatectomy at a Large-Volume Center
By: Huang M.M. , Patel H.D. , Su Z.T. , Wainger J.J. , Han M. , Pierorazio P.M. , Allaf M.E.
Institutes: The Brady Urological Institute at the Johns Hopkins University School of Medicine, Dept. of Urology, Baltimore, United States of America
346Extraperitoneal versus Transperitoneal single-port robotic radical prostatectomy: A comparative analysis of perioperative outcomes
By: Kaouk J. 1 , Aminsharifi A. 1 , Wilson C.A. 1 , Sawczyn G. 1 , Garisto J. 1 , Francavilla S. 2 , Abern M. 2 , Crivellaro S.C. 2
Institutes: 1Glickman Urological and Kidney Institute, Cleveland Clinic, Dept. of Urology, Cleveland, United States of America, 2University of Illinois, Dept. of Urology, Chicago, United States of America
347Single-port suprapubic transvesical robotic assisted radical prostatectomy: Technique and outcomes
By: Guo J-M. , Jiang S.
Institutes: Zhongshan Hospital Fudan University, Dept. of Urology, Shanghai, China
348Robotic - assisted radical perineal prostatectomy (RAPP) – resurgence of a robust surgical treatment. Initial experience of 12 cases
By: Bolton E. , Russell B.J. , Manson-Bahr D.A. , Wong K.W. , Ogden C.W.
Institutes: Royal Marsden Hospital, Dept. of Urology, London, United Kingdom
349Exogenous 5-aminolevulinic acid sensitizes prostate cancer cells to radiation therapy thorough mitochondria-mediated apoptosis induced by reactive oxygen species
By: Owari T. 1 , Miyake M.M. 1 , Tanaka N.T. 1 , Nakai Y.N. 1 , Itami Y.I. 1 , Kuniyasu H.K. 2 , Fujimoto K.F. 1
Institutes: 1Nara Medical University, Dept. of Urology, Kashihara-shi, Japan, 2Nara Medical University, Dept. of Molecular Pathology, Kashihara-shi, Japan
350A pilot transcriptomic analysis of archival prostate biopsy samples and response to radical radiotherapy
By: Charlton P. 1 , O'reilly D. 1 , Philippou Y. 1 , Rao S. 2 , Lamb A.D. 2 , Higgins G. 1 , Hamdy F.C. 2 , Verrill C. 2 , Bryant R.J. 2 , Buffa F. 1
Institutes: 1University of Oxford, Dept. of Oncology, Oxford, United Kingdom, 2University of Oxford, Nuffield Dept. of Surgical Sciences, Oxford, United Kingdom
351Automated Gleason grading of whole slide prostatectomy images
By: Grogg J. 1 , Arvaniti E. 2 , Gretser S. 3 , Smith K. 3 , Sulser T. 1 , Hermanns T. 1 , Wild P.J. 3 , Fankhauser C.D. 1 , Claassen M. 2
Institutes: 1University of Zurich, Dept. of Urology, Zurich, Switzerland, 2ETH Zurich, Institute for Molecular Systems Biology, Zurich, Switzerland, 3University Hospital Frankfurt, Dr. Senckenberg Institute of Pathology, Frankfurt, Germany
352Accuracy of prostate cancer segmentation for 3D printing and modelling: a comparison between radiologists, urologists and scientists
By: Chen M.Y-C. 1 , Woodruff M.A. 2 , Rukin N.J. 1
Institutes: 1Redcliffe Hospital, Dept. of Urology, Brisbane, Australia, 2Queensland University of Technology, Science and Engineering Faculty, Brisbane, Australia
353A new quality control scoring system for multiparametric MRI of the prostate from the PRECISION trial
By: Giganti F. 1 , Kasivisvanathan V. 2 , Punwani S. 1 , Emberton M. 2 , Allen C. 1 , Moore C.M. 2 , PRECISION Study Group
Institutes: 1University College London Hospital, Dept. of Radiology, London, United Kingdom, 2University College London Hospital, Dept. of Urology, London, United Kingdom
354Ex-vivo experimental 7 tesla high resolution magnetic resonance imaging - of localized prostate cancer
By: Durand M. 1 , Bessede T. 2 , Treacy P-J. 1 , Bentellis I. 1 , Corcuera-Solano I. 2 , Taouli B. 2 , Rastinehad A. 2 , Tang C.Y. 2 , Wang V. 2 , Reddy B. 2 , Raffaelli C. 3 , Fromont G. 4 , Puech P. 5 , Kaines K. 2 , Tewari A. 2 , Villers A. 5
Institutes: 1University Hospital of Nice, Dept. of Urology, Nice, France, 2Icahn School of Medicine at Mount Sinai, Dept. of Urology, New York, France, 3University Hospital of Nice, Dept. of Radiology, Nice, France, 4University Hospital of Rennes, Dept. of Urology, Rennes, France, 5University Hospital of Lille, Dept. of Urology, Lille, France
355Intraoperative fluorescence confocal microscopy of targeted biopsy cores for real time diagnosis of prostate cancer. Initial experience and results
By: Marenco J.L. , Calatrava Fons A. , Casanova Ramon-Borja J. , Wong Gutierrez A. , Gomez-Ferrer Lozano A. , Dominguez Escrig J.L. , Ramírez Backhaus M. , Mir Maresma M.C. , Collado Serra A. , Dumont Martínez R. , Rubio Briones J.
Institutes: Fundacion Instituto Valenciano de Oncologia, Dept. of Urology, Valencia, Spain
356Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian Academic Center
By: Zakaria A.S. 1 , Couture F. 2 , Nguyen D. 3 , Shahine H. 1 , Côme T. 3 , Cristina N. 1 , Law K. 3 , Karakiewicz P. 1 , El-Hakim A. 1 , Zorn K. 1
Institutes: 1University of Montreal Hospital Center, Dept. of Urology, Montreal, Canada, 2University of Sherbrooke Hospital Center, Dept. of Urology, Montreal, Canada, 3McGill University, Dept. of Urology, Montreal, Canada
-
-
-
Green Area, Room 1
-
Meeting of the EAU Section of Female and Functional Urology (ESFFU) - Meeting of the EAU Section of Female and Functional Urology (ESFFU) in cooperation with the EAU Section of Urologists in Office (ESUO)
Meeting of the EAU Section of Female and Functional Urology (ESFFU) in cooperation with the EAU Section of Urologists in Office (ESUO) Meeting of the EAU Section of Female and Functional Urology (ESFFU)
Meeting of the EAU Section of Female and Functional Urology (ESFFU) in cooperation with the EAU Section of Urologists in Office (ESUO)
Meeting of the EAU Section of Female and Functional Urology (ESFFU)
-
Location:Green Area, Room 1
-
Chair:
-
Learning objectives The meeting will address several hot topics in functional urology: Management of male incontinence, the controversy involving synthetic slings for female stress incontinence, treatment options for LUTS in men including nocturia, recent advances in bladder pain syndrome, recurrent UTI in women and an up-date in neuro-urology, including bladder augmentation.
Introduction to the 1st ESFFU
Debate Female stress urinary incontinence -
-
Thematic session 01 - Urinary reconstruction in (neuro)urology
Urinary reconstruction in (neuro)urology Thematic session 01
Urinary reconstruction in (neuro)urology
Thematic session 01
-
Location:Green Area, Room 1
-
Chairs:
-
Learning objectives After the introduction of botulinum toxin A in the armamentarium of neurogenic bladder dysfunction, other more complex treatment options have been very much ignored. However Botulinum toxin does not work in every case. Advances in sacral neuromodulation have occurred and may prove useful for neurogenic patients. Urinary diversion may be a realistic option in complex cases, and urologists need to familiarize themselves with other neurological problems in addition to MS or SCI. Parkinson’s disease is a good example of a disease with multiple urological problems urologists that should be aware of.
Debate What happens if Botox does not work in MS anymore? -
-
Thematic session 12 - The new EAU guidelines on Male Sexual and Reproductive Health: Challenges and controversies
The new EAU guidelines on Male Sexual and Reproductive Health: Challenges and controversies Thematic session 12
The new EAU guidelines on Male Sexual and Reproductive Health: Challenges and controversies
Thematic session 12
-
Location:Green Area, Room 1
-
Chairs:
-
Learning objectives The previous and historical guidelines topics on sexual dysfunction, male infertility and hypogonadism have now been amalgamated into a single guidelines topic (SRH), with the specific aim to further develop the concept of men’s health. In this dedicated thematic session, the SRH guidelines group will present the new EAU guidelines on SRH. In particular the session will focus on novel and controversial areas in the new guidelines.
-
-
Poster Session 34 - Urethral strictures: Timing, assessment of techniques and predictive factors for success and failure
Urethral strictures: Timing, assessment of techniques and predictive factors for success and failure Poster Session 34
Urethral strictures: Timing, assessment of techniques and predictive factors for success and failure
Poster Session 34
453Evaluation of a collagen cell carrier for urethral reconstructive surgery using a biological simulation model
By: Aufderklamm S. , Stenzl A. , Amend B.
Institutes: University Hospital of Tuebingen, Dept. of Urology, Tübingen, Germany
454Serum testosterone is lower in non-idiopathic than in idiopathic anterior urethral strictures
By: Puche-Sanz I. 1 , Sabio-Bonilla A. 2 , Sanchez-Conde V. 2 , Vicente-Prados J. 2 , Expósito M. 3 , Cózar-Olmo J.M. 1
Institutes: 1Hospital Universitario Virgen de las Nieves. Inst Invest Biosanitaria Ibs GRANADA., Dept. of Urology, Granada, Spain, 2Hospital Universitario Virgen de las Nieves., Dept. of Urology, Granada, Spain, 3Fundación para la Investigación Biosanitaria de Andalucía Oriental (FIBAO)., Dept. of Biostatistics, Granada, Spain
455Does urethral rest with supra pubic catheter influence urethrographic results and surgical planning in urethral stricture patients?
By: Roizman S.R 1 , Zisman A. 1 , Chertin B. 2 , Shenfeld O 2
Institutes: 1Shamir Medical Center, Dept. of Urology, Tel Aviv, Israel, 2Shaare Zedek Medical Center, Dept. of Urology, Jerusalem, Israel
456Structural analysys of the bulbospongiosus muscle in patients with bulbar urethral strictures
By: Alves E.F. , Favorito L.A. , Costa W.S. , Gallo C.B.M. , Passos M.A. , Sampaio F.
Institutes: State University of Rio de Janeiro, Dept. of Urogenital Research, Rio de Janeiro, Brazil
457Morphological factors enhancing the acceptance of buccal grafts in reconstructive urology
By: Mitusov V.V. 1 , Voronova O. 2 , Mirzaev Z.A. 1 , Glukhov V.P. 1 , Amirbekov B.G. 1
Institutes: 1Rostov State Medical University, Dept. of Urology and Human Reproductive Health with Pediatric Urology and Andrology, Rostov-on-Don, Russia, 2Rostov State Medical University, Dept. of Operative Surgery, Clinical Anatomy and Pathological Anatomy, Rostov-on-Don, Russia
458Predictive value of MRI geometric parameters to the surgical complexity of pelvic fracture urethral stricture
By: Song L.J. 1 , Wang Z.Y. 1 , Song G.P 2 , Xiao Y.F. 2 , Zhang J. 1 , Fu Q. 1
Institutes: 1Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Dept. of Urology, Shanghai, China, 2Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Dept. of Radiology, Shanghai, China
459What's the role of peri-catheter urethrography before catheter removal in anterior urethroplasty
By: Hasab El-Naby A. 1 , Reda A. 1 , Abdalla M. 1 , Osman M. 2
Institutes: 1Asyut Urology and Nephrology Ceneter, Dept. of Urology, Asyut, Egypt, 2Asyut urology Nephrology Center, Dept. of Urology, Asyut, Egypt
460Radiological re-evaluation of failed anastomotic posterior urethroplasty for PFUDDI
By: Hasab El-Naby A. , Abdalla M.
Institutes: Asyut urology Nephrology Center, Dept. of Urology, Asyut, Egypt
461Withdrawn
463Outcomes of reconstruction following pelvic fracture urethral injury
By: Ferrara S. , Remondini T. , Hird A. , Locke J. , Herschorn S. , Kodama R.
Institutes: Sunnybrook Health Sciences Centre, Dept. of Urology, Toronto, Canada
464The impact of pain and postoperative complications on outcome in patients treated with buccal mucosa graft urethroplasty – results of a randomized controlled study
By: Fuehner C. , Vetterlein M.W. , Leßke J. , Ludwig T. , Meyer C.P. , Gild P. , Maurer V. , Engel O. , Dahlem R. , Rink M. , Fisch M. , Soave A.
Institutes: University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany
465How and for how long should patients be followed up after bulbar or bulbomembranous urethroplasty?
By: Bugeja S. , Frost A. , Ivaz S. , Jeffrey N. , Dragova M. , Lomiteng A. , Andrich D.E. , Mundy A.R.
Institutes: University College London Hospitals, NHS Foundation Trust, Reconstructive Urology Unit, London, United Kingdom
466A multivariable analysis of preoperative factors predicting endoscopic recurrence of stricture after urethroplasty
By: Mangir N. , Rodriguez Lopez S. , Osman N. , Inman R. , Chapple C.
Institutes: Royal Hallamshire Hospitals, Dept. of Urology, Sheffield, United Kingdom
467Effectiveness of the endoscopic correction of vesicourethral anastomosis strictures after radical prostatectomy
By: Keshishev N. , Serebryaniy S.A. , Polyakov N.V. , Sidiropoulos A.
Institutes: N.A. Lopatkin Research Institute of Urology and Interventional Radiology, FSBI NMRRC of the Ministry of Health of Russia, Moscow, Russia
-
Poster Session 61 - Metastatic RCC: The impact of surgery
Metastatic RCC: The impact of surgery Poster Session 61
Metastatic RCC: The impact of surgery
Poster Session 61
* 834Nephrectomy after complete response to immune checkpoint inhibitors for Metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge?
By: Pignot G. 1 , Thiery-Vuillemin A. 2 , Walz J. 1 , Lang H. 3 , Werle P. 3 , Balssa L. 4 , Geoffrois L. 5 , Leblanc L. 6 , Albigès L. 7 , Di Nunno V. 7 , Bensalah K. 8 , Ladoire S. 9 , Gravis G. 10 , Barthélémy P. 11
Institutes: 1Institut Paoli-Calmettes, Dept. of Surgical Oncology 2, Marseille, France, 2CHRU Besancon, Hopital Jean Minjoz, Dept. of Medical Oncology, Besançon, France, 3University hospital of Strasbourg, Dept. of Urology, Strasbourg, France, 4CHRU Besancon, Hopital Jean Minjoz, Dept. of Urology, Besançon, France, 5Institut de cancérologie de Lorraine, Dept. of medical oncology, Vandoeuvre lès Nancy, France, 6CHRU Nancy, Hôpitaux de Brabois, Dept. of Urology, Vandoeuvre lès Nancy, France, 7Institut Gustave Roussy, Dept. of medical oncology, Villejuif, France, 8CHU Rennes, Hopital Pontchaillou, Dept. of Urology, Rennes, France, 9Centre Georges-François Leclerc, Dept. of medical oncology, Dijon, France, 10Institut Paoli-Calmettes, Dept. of Medical Oncology, Marseille, France, 11University hospital of Strasbourg, Dept. of Medical Oncology, Strasbourg, France
835Variations in the exposure to sunitinib with immediate and deferred cytoreductive nephrectomy (CN). A post-hoc analysis of the randomized controlled EORTC SURTIME trial
By: Abu-Ghanem Y. 1 , Van Thienen H. 2 , Blank C. 2 , Powles T. 3 , Collette L. 4 , Tombal B. 5 , Haanen J. 2 , Bex A. 6
Institutes: 1Sheba Medical Centre, Dept. of Urology, Ramat-Gan, Israel, 2The Netherlands Cancer Institute, Dept. of Oncology, Amsterdam, The Netherlands, 3Barts Cancer Centre, Dept. of Oncology, London, United Kingdom, 4EORTC, Statistics, Brussels, Belgium, 5Catholic University Louvain, Dept. of Urology, Brussels, Belgium, 6The Netherlands Cancer Institute, Dept. of Urology, Amsterdam, The Netherlands
836Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score
By: Mir Maresma M.C. 1 , Marchioni M. 2 , Campi R. 3 , Minervini A. 3 , Kriegmair M. 4 , Heck M. 5 , Porpiglia F. 6 , Van Bruwaene S. 7 , Linares E. 8 , Hevia V. 9 , Musquera M. 10 , Derweesh I. 11 , Ghali F. 11 , Autorino R. 12 , Veccia A. 12 , Roussel E. 13 , Albertsen M. 13 , Pavan N. 14 , Antonellia A. 15 , Palumbo C. 15 , Capitanio U. 16 , Klatte T. 17 , Erdem S. 18 , Rubio-Briones J. 19 , YAU Renal Cancer Group
Institutes: 1FUndacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain, 2SS Annunziata Hospital, , Dept. of Urology, Chieti, Italy, 3University of Florence, Careggi Hospital, Florence, Italy., Dept. of Urology, Florence, Italy, 4University Medical Centre Mannheim, Mannheim, Germany, Dept. of Urology, Mannheim, Germany, 5Technical University of Munich, Munich, Germany, Dept. of Urology, Munich, Germany, 6School of Medicine, University of Turin-San Luigi Gonzaga Hospital, Dept. of Urology, Turin, Italy, 7AZ Groeninge, Dept. of Urology, Kortrijk, Belgium, 8Hospital La Paz, Dept. of Urology, Madrid, Spain, 9Hospital Ramon y Cajal, Dept. of Urology, Madrid, Spain, 10Hospital Clinic, Dept. of Urology, Barcelona, Spain, 11UC San Diego Moores Cancer Center, University of California San Diego School of Medicine, Dept. of Urology, San Diego, United States of America, 12VCU Medical Center, Dept. of Urology, Richmond, United States of America, 13UKLeuven, Dept. of Urology, Leuven, Belgium, 14University of Trieste, Dept. of Urology, Trieste, Italy, 15Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 16IRCCS Ospedale San Raffaele., Dept. of Urology, Milan, Italy, 17Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Dept. of Urology, Cambridge, United Kingdom, 18Istanbul University, Dept. of Urology, Istanbul, Turkey, 19Fundacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain
837Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
By: Roussel E. 1 , Campi R. 2 , Minervini A. 2 , Kriegmair M. 3 , Heck M. 4 , Klatte T. 5 , Kara Ö. 6 , Bertolo R. 7 , Erdem S. 8 , Capitanio U. 9 , Van Bruwaene S. 10 , Albersen M. 1 , Linares E. 11 , Antonelli A. 12 , Rubio J. 13 , Pavan N. 14 , Autorino R. 15 , Derweesh I. 16 , Musqueara M. 17 , Hevia V. 18 , Porpiglia F. 19 , Ouzaid I. 20 , Mir M.C. 13 , Young Academic Urologists Renal Cancer Working Group
Institutes: 1University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, 2University of Florence, Dept. of Urology, Florence, Italy, 3University Medical Centre Mannheim, Dept. of Urology, Mannheim, Germany, 4Technical University of Munich, Dept. of Urology, Munich, Germany, 5Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Dept. of Urology, Bournemouth, United Kingdom, 6Kocaeli University, Dept. of Urology, Kocaeli, Turkey, 7San Carlo di Nancy, Dept. of Urology, Rome, Italy, 8Istanbul University, Dept. of Urology, Istanbul, Turkey, 9Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 10AZ groeninge, Dept. of Urology, Kortrijk, Belgium, 11Hospital La Paz, Dept. of Urology, Madrid, Spain, 12Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 13Fundacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain, 14University of Trieste, Dept. of Medical, Surgical and Health Science, Trieste, Italy, 15VCU Medical Center, Dept. of Urology, Richmond, United States of America, 16UC San Diego Moores Cancer Center, Dept. of Urology, San Diego, United States of America, 17Hospital Clinic, Barcelona, Dept. of Urology, Barcelona, Spain, 18Hospital Ramon y Cajal, Dept. of Urology, Madrid, Spain, 19University of Turin-San Luigi Gonzaga Hospital, Dept. of Urology, Turin, Italy, 20University of Zielona Góra,, Dept. of Urology, Zielona Góra, Poland
838The role of cytoreductive nephrectomy in the contemporary management of metastatic kidney cancer: Predictive factors for surgical complications and oncological survival
By: Roussel E. 1 , Verbiest A. 2 , Milenkovic U. 1 , Everaerts W. 1 , Van Cleynenbreugel B. 1 , Van Poppel H. 1 , Joniau S. 1 , Beuselinck B. 2 , Devos G. 1 , Muilwijk T. 1 , Albersen M. 1
Institutes: 1University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, 2University Hospitals Leuven, Dept. of Medical Oncology, Leuven, Belgium
839Lymph node dissection is associated with decreased survival and all cause mortality among patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma
By: Weprin S. , Nandanan N. , Veccia A. , Falagario U. , Grob B.M. , Guruli G. , Hampton L. , Autorino R.
Institutes: Virginia Commonwealth University, Dept. of Urology, Richmond, United States of America
840Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registry
By: Campi R. 1 , Marchioni M. 2 , Roussel E. 3 , Capitanio U. 4 , Klatte T. 5 , Kriegmair M. 6 , Erdem S. 7 , Rubio-Briones J. 8 , Minervini A. 1 , Heck M. 9 , Porpiglia F. 10 , Van Bruwaene S. 11 , Linares E. 12 , Hevia V. 13 , Musquera M. 14 , Derweesh I. 15 , Autorino R. 16 , Pavan N. 17 , Antonelli A. 18 , Palumbo C. 18 , Guruli G. 16 , Ghali F. 15 , Amiel T. 9 , Mir M. 8 , YAU Renal Cancer Group
Institutes: 1University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 2SS Annunziata Hospital, Dept. of Urology, Chieti, Italy, 3KU Leuven , Dept. of Urology, Leuven, Belgium, 4IRCCS Ospedale San Raffaele, Dept. of Urology, Dept. of Oncology, Urological Research Institute, Milan, Italy, 5Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Dept. of Urology, Cambridge, United Kingdom, 6University Medical Centre Mannheim, Dept. of Urology, Mannheim, Germany, 7University of Istambul, Dept. of Urology, Istanbul, Turkey, 8Fundacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain, 9Technical University of Munich, Dept. of Urology, Munich, Germany, 10University of Turin-San Luigi Gonzaga Hospital, Dept. of Urology, School of Medicine, Turin, Italy, 11AZ Groeninge, Dept. of Urology, Kortrijk, Belgium, 12Hospital La Paz, Dept. of Urology, Madrid, Spain, 13Hospital Ramon y Cajal, Dept. of Urology, Madrid, Spain, 14Hospital Clinic, Dept. of Urology, Barcelona, Spain, 15UC San Diego Moores Cancer Center, University of California San Diego School of Medicine, Louisiana Jolla, Dept. of Urology, San Diego, United States of America, 16VCU Medical Center, Dept. of Urology, Richmond, United States of America, 17Surgical and Health Science, University of Trieste, Dept. of Urology, Trieste, Italy, 18Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy
841The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: A retrospective analysis of a contemporary series
By: Marchioni M. 1 , Campi R. 2 , Minervini A. 2 , Klatte T. 3 , Kriegmair M. 4 , Erdem S. 5 , Capitanio U. 6 , Roussel E. 7 , Albertsen M. 7 , Heck M. 8 , Porpiglia F. 9 , Van Bruwaene S. 10 , Linares E. 11 , Hevia V. 12 , Musquera M. 13 , Derweesh I. 14 , Autorino R. 15 , Pavan N. 16 , Antonelli A. 17 , Rubio-Briones J. 18 , Vecchia A. 15 , Checcucci E. 9 , Claps F. 16 , Mir M.C. 18 , YAU Renal Cancer Group
Institutes: 1Department of Urology, SS Annunziata Hospital,, Dept. of Urology, Chieti, Italy, 2Department of Urology, University of Florence, Careggi Hospital, Florence, Italy., Dept. of Urology, Florence, Italy, 3Department of Urology, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK., Dept. of Urology, Cambridge, United Kingdom, 4Department of Urology, University Medical Centre Mannheim, Mannheim, Germany, Dept. of Urology, Mannheim, Germany, 5Istanbul University, Istanbul Faculty of Medicine, Dept. of Urology, Istanbul, Turkey, 6Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Dept. of Urology, Milan, Italy, 7Department of Urology- UKLeuven, Leuven, Belgium, Dept. of Urology, Leuven, Belgium, 8Department of Urology, Technical University of Munich, Munich, Germany, Dept. of Urology, Munich, Germany, 9Department of Urology, School of Medicine, University of Turin-San Luigi Gonzaga Hospital, Turin, Italy, Dept. of Urology, turin, Italy, 10Department of Urology, AZ Groeninge, Kortrijk, Belgium, Dept. of Urology, Kortrijk, Belgium, 11Department of Urology, Hospital La Paz, Madrid, Spain, Dept. of Urology, Madrid, Spain, 12Department of Urology, Hospital Ramon y Cajal, Madrid, Spain, Dept. of Urology, Madrid, Spain, 13Department of Urology, Hospital Clinic, Barcelona, Spain., Dept. of Urology, Barcelona, Spain, 14Department of Urology, UC San Diego Moores Cancer Center, University of California San Diego School of Medicine, Louisiana Jolla, California, USA, Dept. of Urology, San Diego, United States of America, 15Division of Urology, VCU Medical Center, Richmond, VA, USA, Dept. of Urology, Richmond, United States of America, 16Urology Clinic, Department of Medical, Surgical and Health Science, University of Trieste, Trieste, Italy, Dept. of Urology, Trieste, Italy, 17Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, ItalyAlessandro Antonelli, Dept. of Urology, Brescia, Italy, 18Fundacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain
842Proposal for a two-tier re-classification of stage IV/M1 Renal Cell Carcinoma into M1 (Oligometastatic) and M2 (Polymetastatic) sub stages
By: Meagher M.F. 1 , Mir M. 2 , Rubio J. 2 , Campi R. 3 , Minervini A. 3 , Mari A. 3 , Kriegmair M. 4 , Heck M. 5 , Amiel T. 5 , Van Bruwaene S. 6 , Porpiglia F. 7 , Checcucci E. 7 , Linares E. 8 , Hevia V. 9 , Musquera M. 10 , Bradshaw A. 1 , Ghali F. 1 , Patel D. 1 , Autorino R. 11 , Rousel E. 12 , Pavan N. 13 , Antonelli A. 14 , Marchioni M. 15 , Mckay R. 1 , Derweesh I. 1
Institutes: 1UC San Diego School of Medicine, Dept. of Urology, La Jolla, United States of America, 2Fundacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain, 3University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 4University Medical Centre Mannheim, Dept. of Urology, Mannheim, Germany, 5Technical University of Munich, Dept. of Urology, Munich, Germany, 6AZ Groeninge, Dept. of Urology, Kortrijk, Belgium, 7University of Turin, San Luigi Gonzaga Hospital, Dept. of Urology, Turin, Italy, 8Hospital La Paz, Dept. of Urology, Madrid, Spain, 9Hospital Ramon y Cajal, Dept. of Urology, Madrid, Spain, 10Hospital Clinic, Dept. of Urology, Barcelona, Spain, 11VCU Medical Center, Dept. of Urology, Richmond, United States of America, 12KU Leuven, Dept. of Urology, Leuven, Belgium, 13University of Trieste, Dept. of Urology, Trieste, Italy, 14Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 15University of Chieti, Dept. of Urology, Chieti, Italy
843Outcome after resection of isolated single- or oligometastatic lymph node metastases at the time of nephrectomy
By: Kuusk T. 1 , Zondervan P. 2 , Lagerveld B. 3 , Rosenzweig B. 4 , Raman A. 5 , Blok J. 6 , De Bruijn R. 7 , Graafland N. 6 , Hendricksen K. 6 , Capitanio U. 8 , Minervini A. 9 , Grant S. 10 , Ljundberg B. 11 , Horenblas S. 6 , Bex A. 1
Institutes: 1Royal Free Hospital, Dept. of Urology, renal cancer unit, London, United Kingdom, 2Academic Medical Center, Dept. of Urology, Amsterdam, The Netherlands, 3OLVG, Dept. of Urology, Amsterdam, The Netherlands, 4The Chaim Sheba Medical Center, Dept. of Urology, Ramat Gan, Israel, 5John Hunter Hospital, Dept. of Urology, Newcastle, Australia, 6Antoni Van Leeuwenhoek Netherlands Cancer Institute, Dept. of Urology, Amsterdam, The Netherlands, 7Amstelland Hospital, Dept. of Urology, Amstelveen, The Netherlands, 8Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Dept. of Urology, Milan, Italy, 9Careggi Hospital, University of Florence, Dept. of Urology, Florence, Italy, 10University of Cambridge, Dept. of Surgery, Academic Urology Group, Cambridge, United Kingdom, 11Umeå University, Dept. of Surgical and Perioperative Sciences, Umeå, Sweden
844Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era
By: Toshio T. , Fukuda H. , Ishihara H. , Yoshida K. , Kondo T. , Hirohito K. , Iizuka J. , Masayoshi O. , Ishida H. , Tanabe K.
Institutes: Tokyo Women's Medical University, Dept. of Urology, Tokyo, Japan
845The impact of metastasis location on overall survival among patients with renal cell carcinoma
By: Patel D. , Ghali F. , Dutt R. , Meagher M. , Keiner C. , Miller N. , Murphy J. , Derweesh I.
Institutes: UCSD, Dept. of Urology, San Diego, United States of America
846Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
By: Meagher M.F. 1 , Mir M. 2 , Rubio J. 2 , Campi R. 3 , Minervini A. 3 , Kriegmair M. 4 , Heck M. 5 , Van Bruwaene S. 6 , Linares E. 7 , Hevia V. 8 , Musquera M. 9 , D’anna M. 9 , Ghali F. 1 , Patel D. 1 , Bradshaw A. 1 , Autorino R. 10 , Guruli G. 10 , Rousel E. 11 , Albertsen M. 11 , Pavan N. 12 , Claps F. 12 , Antonelli A. 13 , Palumbo C. 13 , Marchioni M. 14 , Derweesh I. 1
Institutes: 1University of California San Diego School of Medicine, Dept. of Urology, La Jolla, United States of America, 2Fundacion Instituto Valenciano Oncologia, Dept. of Urology, Valencia, Spain, 3University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 4University Medical Centre Mannheim, Dept. of Urology, Mannheim, Germany, 5Technical University of Munich, Dept. of Urology, Munich, Germany, 6AZ Groeninge, Dept. of Urology, Kortrijk, Belgium, 7Hospital La Paz, Dept. of Urology, Madrid, Spain, 8Hospital Ramon y Cajal, Dept. of Urology, Madrid, Spain, 9Hospital Clinic, Dept. of Urology, Barcelona, Spain, 10VCU Medical Center, Dept. of Urology, Richmond, United States of America, 11UKLeuven, Dept. of Urology, Leuven, Belgium, 12University of Trieste, Dept. of Medical, Surgical and Health Science, Trieste, Italy, 13Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 14University of Chieti, Dept. of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, Chieti, Italy
847Safety and efficacy of Cyberknife radiosurgery for visceral and lymph node metastases of renal cell carcinoma – a retrospective, single center analysis
By: Rodler S. 1 , Schott M. 1 , Tamalunas A. 1 , Marcon J. 1 , Graser A. 1 , Casuscelli J. 1 , Stief C. 1 , Fürweger C. 2 , Muacevic A. 2 , Staehler M. 1
Institutes: 1University Hospital, Ludwig Maximilian University of Munich, Dept. of Urology, Munich, Germany, 2European Cyberknife Center, Munich, Germany
-
Poster Session 10 - Prostate cancer: Occupational exposure, ethnicity and risk
Prostate cancer: Occupational exposure, ethnicity and risk Poster Session 10
Prostate cancer: Occupational exposure, ethnicity and risk
Poster Session 10
* 117Ethnic variation in prostate cancer detection: A hypothesis generating study for use of the stockholm3 test in an american cohort
By: Vigneswaran H.T. 1 , Discacciati A. 2 , Gann P. 3 , Grönberg H. 2 , Eklund M. 2 , Abern M.R. 1
Institutes: 1University of Illinois at Chicago, Dept. of Urology, Chicago, United States of America, 2Karolinska Institutet, Dept. of Medical Epidemiology and Biostatistics, Stockholm, Sweden, 3University of Illinois at Chicago, Dept. of Pathology, Chicago, United States of America
* 118Spironolactone use is associated with lower risk of prostate cancer
By: Beckmann K. 1 , Garmo H. 2 , Lindahl B. 3 , Holmberg L. 1 , Stattin P. 4 , Adolfsson J. 5 , Cruickshank K. 6 , Van Hemelrijck M. 1
Institutes: 1Kings College London, Dept. of Translational Oncology and Urology Research (TOUR), London, United Kingdom, 2Uppsala University, Regional Cancer Center, Uppsala, Sweden, 3Uppsala University, Uppsala Clinical Research Center, Uppsala, Sweden, 4Uppsala University, Dept. of Surgical Sciences, Uppsala, Sweden, 5Karolinska Institutet, CLINTEC-Department, Stockholm, Sweden, 6Kings College London, Dept. of Nutritional Studies, London, United Kingdom
* 119Occupational exposure and risk of genitourinary malignancies: A Canadian population study
By: Nair S.M. 1 , Luu Ly T. 2 , Lavi A. 1 , Sano Y. 2 , Haan M. 2 , Power N.E. 1
Institutes: 1Western University, Dept. of Urology, Dept. of Surgery, London, Canada, 2Western University, Dept. of Sociology, London, Canada
120Global variations in treatment decisions among men with localized prostate cancer: Patterns of care in 15,718 men from 9 countries
By: Pearman E. 1 , Ferrer M.F.F 2 , Kowalski C.K 3 , Kwan L.K 1 , Bolagani A.B 1 , Belin T.R.B 1 , Elashoff D.E 1 , Breidenbach C.B 3 , Dieng S.D 3 , Ferencz J.F 3 , Hein R.H 3 , Tabea Sibert N.T.S 3 , Pont Acuña A.P.A 2 , Garin Boronat O.G.B 2 , Evans S.E 4 , Opie J.O 4 , Sampurno F.S 4 , Connor S.E.C 1 , Moore C.M 5 , Millar J.M 4 , Vilanti P.V 6 , Litwin M.S.L 1
Institutes: 1University of California, Los Angeles, Dept. of Urology, Los Angeles, United States of America, 2IMIM, Dept. of Urology, Barcelona, Spain, 3German Cancer Soceity, Dept. of Urology, Berlin, Germany, 4Monash University, Dept. of Urology, Melbourne, Australia, 5University College London, Dept. of Urology, London, United Kingdom, 6Movember, Dept. of Urology, Melbourne, Australia
122Vitamin D level and mortality risk among Danish men with prostate cancer
By: Stroomberg H.V. 1 , Juhl Vojdeman F. 2 , Medom Madsen C. 2 , Helgstrand J.T. 1 , Schwarz P. 3 , Heegaard A-M. 4 , Hansen L. 5 , Olsen A. 5 , Tjønneland A. 5 , Struer Lind B. 6 , Brasso K. 1 , Løvendahl Jørgensen H. 6 , Røder M.A. 1
Institutes: 1Rigshospitalet, Copenhagen Prostate Cancer Center, Dept. of Urology, Copenhagen, Denmark, 2Herlev and Gentofte Hospital, Dept. of Clinical Biochemistry, Copenhagen, Denmark, 3Rigshospitalet, Copenhagen Prostate Cancer Center, Dept. of Endocrinology, Copenhagen, Denmark, 4Copenhagen University, Dept. of Drug Design and Pharmacology, Copenhagen, Denmark, 5The Danish Cancer Society, Research Center, Copenhagen, Denmark, 6Amager and Hvidorve Hospital, Dept. of Clinical Biochemistry, Copenhagen, Denmark
123Frequency of ejaculation: A factor associated with a higher risk of prostate cancer. CAPLIFE study
By: Melgarejo Segura M.T. 1 , Jimenez-Pacheco A. 1 , Lozano-Lorca M. 2 , Vazquez Alonso F. 3 , Arrabal-Polo M.A. 1 , Sanchez-Tamayo J. 1 , Arrabal-Martin M. 1 , Jimenez-Moleon J.J. 4 , Olmedo-Requena R. 4
Institutes: 1HOSPITAL UNIVERSITARIO CLINICO SAN CECILIO, Dept. of UROLOGY, Granada, Spain, 2GRANADA UNIVERSITY, PREVENTIVE MEDICINE AND HEALTH PUBLIC, Granada, Spain, 3HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES, Dept. of UROLOGY, Granada, Spain, 4GRANADA UNIVERSITY, PREVENTIVE MEDICINE AND PUBLIC HEALTH, Granada, Spain
124The effect of age on cancer-specific mortality in patients with prostate cancer: A population-based study across all stages
By: Knipper S. 1 , Pecoraro A. 2 , Palumbo C. 2 , Rosiello G. 2 , Luzzago S. 2 , Deuker M. 2 , Tian Z. 2 , Shariat S. F. 3 , Saad F. 2 , Tilki D. 1 , Graefen M. 1 , Karakiewicz P.I. 2
Institutes: 1Martini-Klinik am UKE, Dept. of Urology, Hamburg, Germany, 2Centre de Recherche, Centre Hospitalier d'Universite de Montreal, Dept. of Urology, Montreal, Canada, 3University Hospital Vienna, Dept. of Urology, Vienna, Austria
125The deleterious association between proton pump inhibitors and prostate cancer-specific death – a population-based cohort study
By: Goldberg HG 1 , Mohsin F. 2 , Saskin R. 3 , Kulkarni G. 1 , Berlin A. 4 , Kenk M. 1 , Wallis C. 1 , Chandeasekar T. 5 , Klaassen Z. 6 , Saarela O. 2 , Penn L. 1 , Shabbir A. 7 , Fleshner N. 1
Institutes: 1University Health Network, University of Toronto, Dept. of Surgical Oncology, Toronto, Canada, 2University of Toronto, Dalla Lana School of Public Health, Toronto, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, Canada, 4University Health Network, University of Toronto, Dept. of Radiation Oncology, Toronto, Canada, 5Sidney Kimmel Cancer Center, Thomas Jefferson University, Dept. of Urology, Philadelphia, United States of America, 6Medical College of Georgia, Augusta University, Dept. of Surgery, Augusta, United States of America, 7University Health Network, University of Toronto, Dept. of Medicine, Toronto, Canada
126Prostate cancer and hispanic men: Unmasking the diversity and data
By: Krimphove M.J. 1 , Gomez G. 2 , Kibel A.S. 2 , Kluth L.A. 2 , Kilbridge K.L. 3 , Seisen T. 4 , Trinh Q. 2
Institutes: 1University Hospital Frankfurt, Dept. of Urology, Frankfurt, Germany, 2Brigham and Women's Hospital, Harvard Medical School, Dept. of Urological Surgery and Center for Surgery and Public Health, Boston, United States of America, 3Dana Farber Cancer Institute, Harvard Medical School, Lank Center for Genitourinary Oncology, Boston, United States of America, 4Hôpital Pitié-Salpetrière, Sorbonne Université, Dept. of Urology, Paris, France
127Cost-effectiveness of the diagnostic pathway for prostate cancer: Healthcare expenses, surgical and oncologic outcomes
By: Soligo M. 1 , Zanovello N. 1 , Prayer Galetti T. 1 , Zattoni F. 2 , Dal Moro F. 2 , Calì D. 1 , Zattoni F. 1 , Morlacco A. 1
Institutes: 1University of Padova, Dept. of Urology, Padova, Italy, 2Azienda Ospedaliera Santa Maria della Misericordia, Dept. of Urology, Udine, Italy
-
Patient information
Patient information
-
Poster Session 71 - Innovations in translational research in renal cancer
Innovations in translational research in renal cancer Poster Session 71
Innovations in translational research in renal cancer
Poster Session 71
-
Location:Green Area, Room 1
-
Chairs:
-
Learning objectives There is still a number of unsolved questions related to development and progression of renal cancer. In this session, New regulatory mechanisms such as those involving specific miRNA and experimental therapy approaches will be presented and discussed.
* 982Transcriptomic characterization of renal cell carcinoma patients with progressive disease despite low initial risk of progression
By: Nakken S. 1 , Eikrem Ø. 1 , Marti H-P. 1 , Beisland C. 1 , Scherer A. 2 , Beisvag V. 3 , Flatberg A. 3 , Strauss P. 1
Institutes: 1University of Bergen, Dept. of Clinical Medicine, Bergen, Norway, 2University of Helsinki, Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland, 3Norwegian University of Science and Technology, Dept. of Clinical and Molecular Medicine, Trondheim, Norway
983Serum levels of the IL-33 decoy receptor soluble ST2; a possible prognostic marker in clear-cell renal cell carcinoma
By: Aarstad H.H. 1 , Gudbrandsdottir G. 1 , Hjelle K.M. 2 , Tvedt T.H.A. 3 , Bruserud Ø. 4 , Bostad L. 5 , Aarstad H.J. 6 , Beisland C. 1
Institutes: 1Haukeland University Hospital, Dept. of Urology, Bergen, Norway, 2University of Bergen, Dept. of Clinical Medicine, Bergen, Norway, 3Haukeland University Hospital, Dept. of Internal Medicine, Bergen, Norway, 4University of Bergen, Dept. of Clinical Science, Bergen, Norway, 5Haukeland University Hospital, Dept. of Pathology, Bergen, Norway, 6Haukeland University Hospital, Dept. of Otorhinolaryngology/Head and Neck Surgery, Bergen, Norway
* 984Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
By: Yan L. , Liu H. , Sun G. , Zhang Y.
Institutes: Tongji Hospital,Tongji Medical College, Huazhong University of Science Technology, Dept. of Urology, Wuhan, China
* 986Therapeutic efficacy and tolerability of [225Ac]Ac-DOTA-hG250 targeted alpha therapy in a clear cell renal cell carcinoma mice model
By: Merkx R. 1 , Kip A. 1 , Franssen G.M. 1 , Oosterwijk E. 2 , Morgenstern A. 3 , Bruchertseifer F. 3 , Wheatcroft M. 4 , Yan E. 4 , Rijpkema M. 1 , Heskamp S. 1 , Mulders P.F.A. 2
Institutes: 1Radboudumc, Dept. of Radiology & Nuclear Medicine, Nijmegen, The Netherlands, 2Radboudumc, Dept. of Urology, Nijmegen, The Netherlands, 3Joint Research Centre, Institute of Transuranium Elements, Karlsruhe, Germany, 4Telix Pharmaceuticals, Research and Development, Melbourne, Australia
987VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of the epidermal growth factor receptor gene
By: Liu C. 1 , Liu L. 2 , Hao Y. 1 , Yang F. 1 , Ma L. 1
Institutes: 1Peking University Third Hospital, Dept. of Urology, Beijing, China, 2Beijing University of Chinese Medicine, School of Nursing, Beijing, China
988Tumor-infiltrating TNFRSF9 positive CD8 T cells in renal cell carcinoma hold both exhaustion and effector phenotype and response better to immunotherapy
By: Li Y. 1 , Xu J.J 2 , Guo J.M 1
Institutes: 1Zhongshan Hospital Fudan University, Dept. of Urology, Shanghai, China, 2School of Basic Medical Sciences, Fudan University, Dept. of Biochemistry and Molecular Biology, Shanghai, China
989Exploration of urinary lipid biomarkers in patients with clear cell renal cell carcinoma
By: Tamura K. 1 , Miyake H. 1 , Setou M. 2
Institutes: 1Hamamatsu University School of Medicine, Dept. of Urology, Hamamatsu, Japan, 2Hamamatsu University School of Medicine, Dept. of Cellular and Molecular Anatomy, Hamamatsu, Japan
990Transcriptomic correlates of non-enhancing tumor volume on imaging in clear cell renal cell carcinoma
By: Marcon J. 1 , Duzgol C. 2 , Kuo F. 3 , Weiss K. 1 , Di Natale R.G. 1 , Mano R. 1 , Silagy A.W. 1 , Blum K.A. 1 , Weng S. 1 , Attalla K. 1 , Reznik E. 4 , Coleman J.A. 1 , Russo P. 1 , Ahmed F.S. 5 , Akin O. 2 , Hakimi A.A. 1
Institutes: 1Memorial Sloan Kettering Cancer Center, Urology Service, Dept. of Surgery, New York City, United States of America, 2Memorial Sloan Kettering Cancer Center, Dept. of Radiology, New York City, United States of America, 3Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York City, United States of America, 4Memorial Sloan Kettering Cancer Center, Computational Oncology Service, Department of Epidemiology and Biostatistics, New York City, United States of America, 5Columbia University Medical Center, Dept. of Radiology, New York City, United States of America
991Liquid biopsy in clear cell Renal Cell Carcinoma: Urinary miR-210-3p as emerging specific biomarker
By: Costantini M. 1 , Petrozza V. 2 , Tito C. 3 , Giammusso L.M. 3 , Sorrentino V. 2 , Cacciotti J. 2 , Porta N. 2 , Iaiza A. 3 , Pastore A.L. 4 , Di Carlo A. 2 , Simone G. 1 , Gallucci M. 1 , Carbone A. 4 , Fazi F. 3
Institutes: 1Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 2Regina Elena National Cancer Institute, Dept. of Medico-Surgical Sciences and Biotechnologies, Rome, Italy, 3Regina Elena National Cancer Institute, Dept. of Anatomical, Histological, Forensic & Orthopaedic Sciences, Section of Histology &Medical Embryology, Rome, Italy, 4Regina Elena National Cancer Institute, Dept. of Urology, Latina, Italy
992Emerging role of secreted urinary miR-210-3p as potential biomarker for clear cell renal cell carcinoma metastasis
By: Pastore A.L. 1 , Al Salhi Y. 1 , Fuschi A. 1 , Velotti G. 1 , Capone L. 1 , Simone G. 2 , Tuderti G. 2 , Costantini M. 3 , Gallucci M. 2 , Petrozza V. 4 , Fazi F. 5 , Carbone A. 1
Institutes: 1Sapienza University of Rome, Faculty of Pharmacy and Medicine, Dept. of Urology, Latina, Italy, 2IFO Regina Elena Hospital, Dept. of Urology, Rome, Italy, 3IFO Regina Elena Hospital, Dept. of Human Pathology, Rome, Italy, 4Sapienza University of Rome, Faculty of Pharmacy and Medicine, Dept. of Histopathology, Latina, Italy, 5Sapienza University of Rome, Faculty of Pharmacy and Medicine, Dept. of Histology, Rome, Italy
-
-
Poster Session 15 - Urethral strictures: The quest for the ultimate surgical solution
Urethral strictures: The quest for the ultimate surgical solution Poster Session 15
Urethral strictures: The quest for the ultimate surgical solution
Poster Session 15
186The versatility of the ventral approach to the bulbar urethra: Urethroplasty outcomes in a high volume UK tertiary referral centre
By: Itam S. , Anderson P.C.B.
Institutes: Russells Hall Hospital, Dept. of Genito-Urethral Reconstructive Urology, Dudley, United Kingdom
187Interim analysis of the VeSpAR trial: A randomized controlled trial comparing Vessel-Sparing Anastomotic Repair and transecting anastomotic repair in isolated, short, bulbar urethral strictures
By: Verla W. 1 , Waterloos M. 1 , Waterschoot M. 1 , Van Parys B. 1 , Suarez O. 2 , Giudice C. 3 , Song L. 4 , Spinoit A. 1 , Lumen N. 1
Institutes: 1Ghent University Hospital, Dept. of Urology, Ghent, Belgium, 2Hospital San José Tecnologico de Monterrey, Dept. of Urology, Nuevo Léon, Mexico, 3Hospital Italiano de Buenos Aires, Dept. of Urology, Buenos Aires, Argentina, 4Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Dept. of Urology, Shanghai, China
188Prospective randomized study to compare outcomes of ventral vs. dorsal onlay graft urethroplasty in female urethral stricture
By: Katiyar V.K. , Goel H. , Sharma U. , Sood R.
Institutes: ABVIMS and Dr Ram Manohar Lohia Hospital, Dept. of Urology and Renal transplant, New Delhi, India
189Dorsal versus dorsolateral approach for buccal mucosal graft anterior urethroplasty: A prospective randomized study
By: Maarouf A.M. 1 , Tharwat A. 1 , Nafee M 1 , Mohamed M 1 , Eliwa A. 1 , Reyad A. 2 , Abdallah M 1 , Abozied M. 1
Institutes: 1Zagazig University, Dept. of Urology, Zagazig, Egypt, 2Sohag University, Dept. of Urology, Sohag, Egypt
190Does aetiology of urethral stricture influence the survival of the buccal mucosa graft?
By: Hevia Palacios M. 1 , Fraile A. 2 , Rodríguez-Patrón R. 2 , Santiago M. 2 , Hevia V. 2 , Burgos Revilla J. 2
Institutes: 1HOSPITAL UNIVERSITARIO RAMON Y CAJAL, Madrid, Spain, 2Hospital Universitario Ramon y Cajal, Madrid, Spain
191The role of one-stage buccal mucosal graft urethroplasty for secondary anterior urethral strictures following failed primary hypospadias repair: Long-term outcomes from a high volume referral center
By: Vetterlein M.W. , Stahlberg J. , Bahassan O. , Engel O. , Dahlem R. , Fisch M. , Riechardt S.
Institutes: University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany
192A prospective analysis of patient-reported outcome measures after buccal mucosa graft urethroplasty for bulbar urethral strictures
By: D'Hulst P. , Muilwijk T. , Vander Eeckt K. , Van Der Aa F. , Joniau S.
Institutes: University Hospitals Leuven, Dept. of Urology, Leuven, Belgium
193Dorsal onlay buccal mucosa vs. vaginal-flap “Blandy” urethroplasty for female stricture: A single-center series
By: Peyronnet B. , Zhao L. , Sussman R. , Palmerola R. , Escobar C. , Pape D. , Rosenblum N. , Nitti V. , Brucker B.
Institutes: New York University, Dept. of Urology, New York , United States of America
194Is urethroplasty really more cost-effective than urethral dilatation for primary bulbar urethral strictures?
By: Bugeja S. , Frost A. , Ivaz S. , Jeffrey N. , Dragova M. , Lomiteng A. , Andrich D.E.
Institutes: University College London Hospitals, NHS Foundation Trust, Reconstructive Urology Unit, London, United Kingdom
195Mid-term results of anterior urethroplasty with tissue-engineered oral mucosa graft MukoCell®
By: Karapanos L. 1 , Akbarov I. 1 , Zugor V. 1 , Barbagli G. 2 , Heidenreich A. 1
Institutes: 1University Hospital of Cologne, Dept. of Urology, Cologne, Germany, 2Centro Chirurgico Toscano, Center for Reconstructive Urethral Surgery, Arezzo, Italy
196Urethroplasty for post-radiation urethral strictures
By: Guspanov R. , Kotov S.V.
Institutes: RNIMU after N.I. Pirogov, Dept. of Urology, Moscow, Russia
197Urethroplasty for failed hypospadias repair related strictures in adults: A retrospective analysis with long-term follow-up
By: Verla W. , Van Nieuwenhuyse F. , Spinoit A. , Waterloos M. , Waterschoot M. , Hoebeke P. , Lumen N.
Institutes: Ghent University Hospital, Dept. of Urology, Ghent, Belgium
198Do reconstructive genitourinary sections really improve surgical outcomes? A comparative study between two different periods at an academic institution
By: Fraile Poblador A. , Hevia Palacios M. , Rodríguez-Patrón R. , Santiago M. , Hevia V. , Burgos Revilla J.
Institutes: Hospital Universitario Ramón y Cajal, Dept. of Urology, Madrid, Spain
199Proposed algorithm for management of non-traumatic bulbar urethral strictures
By: Chawla A.K. , Mohan A. , Kapadia A. , Kriplani A.
Institutes: KMC Manipal, MAHE, Dept. of Urology and Renal Transplant, Manipal, India
200Use of gracilis flap interposition in repair of urethrorectal fistulae, whether through a transperineal or transanal approach
By: El Ghoneimy M.M.N. 1 , Abdel Rassoul M. 1 , El Tamimi A. 2
Institutes: 1cairo university, Dept. of urology, Cairo, Egypt, 2urology department, Dept. of urology, ta3ez, Yemen
-
Poster Session 20 - The iatrogenic blues of male stress incontinence, are we out of the dark ages?
The iatrogenic blues of male stress incontinence, are we out of the dark ages? Poster Session 20
The iatrogenic blues of male stress incontinence, are we out of the dark ages?
Poster Session 20
255Bladder elevation in pelvic floor muscle training evaluated by cine MRI (magnetic resonance imaging) is associated with early recovery of continence after radical prostatectomy
By: Shimura H. 1 , Watanabe N. 2 , Nakamura K. 2 , Tsukamoto T. 2 , Kuwahara Y. 2 , Terada S. 3 , Mitsui T. 1 , Takeda M. 1
Institutes: 1Universtiy of Yamanashi, Dept. of Urology, Yamanashi, Japan, 2Nagakubo Hospital, Dept. of Urology, Tokyo, Japan, 3Medical Scaning Nippori, Dept. of Radiology, Tokyo, Japan
256Urodynamic predictors of surgical outcomes following male sling implantation
By: Toia B. 1 , Leung L.Y. 2 , Saigal R. 3 , Solomon E. 3 , Malde S. 3 , Taylor C. 3 , Sahai A. 3 , Hamid R. 1 , Greenwell T. 1 , Seth J. 2 , Sharma D. 2 , Ockrim J. 1
Institutes: 1University College London Hospitals NHS Trust, Dept. of Urology, London, United Kingdom, 2St. George's University Hospitals NHS Foundation Trust, Dept. of Urology, London, United Kingdom, 3Guy's and St Thomas' NHS Foundation Trust, Dept. of Urology, London, United Kingdom
257Contemporary trends of radical prostatectomy and predictors for recovery of urinary continence in the elderly aged >70 years: Comparisons with the cohort aged ≤70 years
By: Jeong S.J. 1 , Song S.H. 1 , Jung J. 2 , Lee Y.J. 1 , Kim H.J. 1 , Lee M.S. 1 , Kim J.H. 3 , Lee S.W. 3 , Byun S-S. 1
Institutes: 1Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea, 2Catholic Kwandong Univerisity International St. Mary’s Hospital, Dept. of Urology, Incheon, South Korea, 3Kangwon National University School of Medicine, Dept. of Urology, Chuncheon, South Korea
258Management of moderate postprostatectomy stress urinary incontinence: a propensity score‐matching analysis comparing artificial urinary sphincter with fixed sling
By: Sacco E.S. , Bientinesi R. , Gandi C. , Vaccarella L. , Bassi P.
Institutes: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Dept. of Urology and Nephrology, Rome, Italy
259Therapeutic efficacy of platelet-rich plasma in treatment of stress urinary incontinence due to intrinsic sphincter deficiency- which patients may benefit?
By: Jiang Y-H. , Lee Y-K. , Kuo H-C.
Institutes: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Dept. of Urology, Hualien, Taiwan
260The first UK experience in using urethral bulking agents to treat men with Stress Urinary Incontinence
By: Yang B. , Foley S. , Britnell W.
Institutes: Royal Berkshire Hospital, Dept. of Urology, Reading, United Kingdom
261The role of external beam radiation therapy for post prostatectomy stress urinary incontinence in transobturator male sling outcomes. A multicentric experience
By: Morselli S. 1 , Li Marzi V. 1 , Baldesi R. 2 , Fantechi R. 1 , Gemma L. 1 , Liaci A. 1 , Di Camillo M. 1 , Traversi C. 2 , Tosto A. 1 , Francesca F. 2 , Gerolamo M. 2 , Serni S. 1
Institutes: 1Careggi Hospital, University of Florence, Dept. of Minimally Invasive and Robotic Urological Surgery and Kidney Transplantation, Florence, Italy, 2AOU Pisa, University of Pisa, Dept. of Urology, Florence, Italy
262Retropubic versus transobturator Argus® adjustable male sling: Results from a multicenter study
By: Kretschmer A. 1 , Hüsch T. 2 , Kirschner-Hermanns R. 3 , Anding R. 4 , Rose A. 5 , Friedl A. 6 , Obaje A. 7 , Brehmer B. 8 , Naumann C.M. 9 , Queissert F. 10 , Pfitzenmaier J. 11 , Nyarangi-Dix J. 12 , Olianas R. 13 , Homberg R. 14 , Abdunnur R. 15 , Schweiger J. 16 , Grabbert M. 17 , Hofmann T. 8 , Wotzka C. 18 , Pottek T. 19 , Hübner W. 20 , Haferkamp A. 21 , Bauer R.M. 22 , Loertzer H. 23
Institutes: 1Ludwig-Maximilians-University Munich, Dept. of. Urology, Munich, Germany, 2University Medical Center Mainz, Dept. of. Urology, Mainz, Germany, 3University Bonn, Dept. of. Neurourology, Bonn, Germany, 4University Bonn, Dept. of Neurology, Bonn, Germany, 5Helios Klinikum Duisburg, Dept. of Urology, Duisburg, Germany, 6Krankenhaus Der Barmherzigen Schwestern Wien, Dept. of Urology, Vienna, Austria, 7St. Bernward Krankenhaus Hildesheim, Dept. of Urology, Hildesheim, Germany, 8Diakonie Klinikum Schwaebisch Hall, Dept. of Urology, Schwäbisch Hall, Germany, 9Marienhausklinikum Bendorf – Neuwied - Waldbreitbach, Dept. of Urology, Bendorf – Neuwied - Waldbreitbach, Germany, 10University Hospital Muenster, Dept. of Urology, Muenster, Germany, 11Evangelisches Klinikum Bethel Bielefeld, Dept. of Urology, Bielefeld, Germany, 12University Hospital Heidelberg, Dept. of Urology, Heidelberg, Germany, 13Klinikum Lueneburg, Dept. of Urology, Lueneburg, Germany, 14St. Barbara Hospital Hamm, Dept. of Urology, Hamm, Germany, 15Helios Klinikum Schwelm, Dept. of Urology, Schwelm, Germany, 16Catholic Hospital Erfurt, Dept. of Urology, Erfurt, Germany, 17University Hospital Freiburg, Dept. of Urology, Freiburg, Germany, 18Diakonie Klinikum Stuttgart, Dept. of Urology, Stuttgart, Germany, 19Vivantes Klinikum Am Urban, Dept. of Urology, Berlin, Germany, 20Landesklinikum Korneuburg, Dept. of Urology, Korneuburg, Germany, 21University Hospital Mainz, Dept. of Urology, Mainz, Germany, 22Ludwig-Maximilians-University Munich, Dept. of Urology, Munich, Germany, 23Westpfalzklinikum Kaiserslautern, Dept. of. Urology, Kaiserslautern, Germany
264Treatment of Post-Prostatectomy Incontinence (PPI) with non-obstructive Slings (n-oS). Results from a real life cohort of ideal and comorbid patients
By: Tasso G.T. 1 , Beels E.B. 2 , Del Favero L.D.F. 2 , Morselli S.M. 2 , Gacci M.G. 1 , Serni S.S. 1 , De Ridder D.D.R. 2 , Van Der Aa F. 2
Institutes: 1Università degli studi di Firenze, Dept. of Urology, Florence, Italy, 2UZ Leuven, Dept. of Urology, Leuven, Belgium
265AdVance (AdV) and AdVance XP (A-XP) slings, comparison of outcomes on ideal and non-ideal patients
By: Tasso G.T. 1 , Beels E. 2 , Spatafora P. 1 , Gacci M. 1 , Serni S. 1 , De Ridder D. 2 , Van Der Aa F. 2
Institutes: 1Università degli Studi di Firenze, Dept. of Urology, Florence, Italy, 2UZ Leuven, Dept. of Urology, Leuven, Belgium
266Outcomes of Virtue® male sling for postprostatectomy incontinence
By: Costa Grau M. , Peri L. , D'anna M. , Franco A. , Álvarez-Vijande R. , Alcaraz A.
Institutes: Hospital Clínic de Barcelona, Dept. of Urology, Barcelona, Spain
267A single center study to evaluate the efficacy and safety of a new adjustable artificial urinary sphincter (victo): Follow-up >12 months
By: Ameli G. , Weibl P. , Rutkowski M. , Hübner W.A.
Institutes: Clinic of Korneuburg, Dept. of Urology, Korneuburg, Austria
2685 year experience on the Adjustable Transobturator Male System (ATOMS) in UK men with stress urinary incontinence®
By: Yang B. , Kowalski P. , Jelley C. , Foley S.
Institutes: Royal Berkshire Hospital, Dept. of Urology, Reading, United Kingdom
269Prospective registry for patients undergoing surgery for male stress urinary incontinence in multiple European centres. an update of the registry ‘SATURN’
By: Van Der Aa F. 1 , Heesakkers J. 2 , Martens F. 2 , Nilsen O.J. 3 , Zachoval R. 4 , De Kort L. 5 , Romero Otero J. 6 , Thiruchelvam N. 7 , Bjartell A. 8 , Caris C. 8 , Schipper R. 8 , Witjes W. 8 , Hamid R. 9
Institutes: 1University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, 2Radboud UMC, Dept. of Urology, Nijmegen, The Netherlands, 3Oslo University Hospital, Dept. of Urology, Oslo, Norway, 4Thomayer Hospital, Dept. of Urology, Prague, Czech Republic, 5UMC Utrecht, Dept. of Urology, Utrecht, The Netherlands, 6University Hospital 12 de Octubre, Dept. of Urology, Madrid, Spain, 7Addenbrooke's Hospital, Dept. of Urology, Cambridge, United Kingdom, 8EAU Research Foundation, Central Research Office, Arnhem, The Netherlands, 9Royal National Orthopaedic Hospital, Dept. of Urology, London, United Kingdom
-
Poster Session 27 - Female stress urinary incontinence: Surgical management
Female stress urinary incontinence: Surgical management Poster Session 27
Female stress urinary incontinence: Surgical management
Poster Session 27
-
Location:Green Area, Room 1
-
Chairs:
-
Learning objectives This session will include recent information in the field of female stress urinary incontinence: epidemiology, advances in medical treatement, criteria for choosing surgery, and outcomes of current surgical approaches.
357Prevalence and trends in urinary incontinence among adult women in the United States 2005-2016
By: Abufaraj M. 1 , Xu T. 2 , Soria F. 1 , Massad A. 3 , Chao C. 4 , Sutcliff S. 5 , Shariat S. 1 , Yang L. 6
Institutes: 1Medical University of Vienna, Dept. of Urology, Vienna, Austria, 2University of Texas Health Science Centre at Houston, Dept. of Biostatistics, Houston, United States of America, 3The University of Jordan, Dept. of Urology, Amman, Jordan, 4Washington University School of Medicine, Program in Physical Therapy, St. Louis, United States of America, 5Washington University School of Medicine, Division of Public Health Sciences, St. Louis, United States of America, 6University of Calgary, Dept. of Oncology and Community Health Sciences, Calgary, Canada
* 358Litoxetine (LTX) shows significant treatment effect in urinary incontinence (UI)
By: Dmochowski R.
Institutes: Vanderbilt University Medical Center, Dept. of Urological Surgery, Nashville, United States of America
359Novel MRI-based evaluation of urinary sphincter function by diffusion tensor imaging to differentiate between rest and contraction
By: Schmid F.A. 1 , Gomolka R.S. 2 , Hötker A.M. 2 , Rossi C. 2 , Eberli D. 1
Institutes: 1University Hospital Zurich, Dept. of Urology, Zurich, Switzerland, 2University Hospital Zurich, Dept. of Radiology, Zurich, Switzerland
360Clinical and urodynamic findings in women affected by mixed urinary incontinence
By: Giannantoni A. 1 , Gubbiotti M. 2 , Balzarro M. 3 , Rubilotta E. 3 , Montibeller N. 1 , Balsamo R. 4 , Pastore A. 5 , Carbone A. 5 , Mancini V. 6 , Finazzi Agrò E. 7 , Carrieri G. 6 , Bini V. 8
Institutes: 1University of Siena, Dept. of Medical and Surgical Sciences and Neurosciences, Functional and Surgical Urology Unit, Siena, Italy, 2Serafico Institute, Assisi, Italy, 3University of Verona, Dept. of Urology, Verona, Italy, 4Monaldi Hospital, Dept. of Urology, Napoli, Italy, 5University of Roma , Dept. of Medical and Surgical Sciences and Biotechnologies, Urology Clinic, Roma, Italy, 6University of Foggia, Dept. of Medical and Surgical Sciences, Foggia, Italy, 7Tor Vergata University Hospital, Unit for Functional Urology, Roma, Italy, 8University of Perugia, Dept. of Medicine, Perugia, Italy
362Identify women undergoing surgery for SUI who will benefit most of a single incision sling
By: Van Der Aa F. 1 , Capon G. 2 , Ryckebusch H. 3 , Ferry P. 4
Institutes: 1UZ Leuven, Dept. of Functional and Reconstructive Urology, Neurourology, Leuven, Belgium, 2Pellegrin hospital, Dept. of Urology, Bordeaux, France, 3Coloplast, Medical Affairs Office, Le Plessis - Robinson, France, 4Saint Louis Hospital, Dept. of Gynaecology, La Rochelle, France
363Interim analysis of a European prospective observational study evaluating patient reported outcomes of altis single incision sling in women operated for stress urinary incontinence
By: Capon G. 1 , Van Der Aa F. 2 , Ryckebusch H. 3 , Ferry P. 4
Institutes: 1Pellegrin hospital, Dept. of Urology, Bordeaux, France, 2UZ Leuven, Functional and reconstructive urology, neurourology, Leuven, Belgium, 3Coloplast, Medical Affairs Office, Le Plessis-Robinson, France, 4Saint Louis Hospital, Dept. of Gynaecology, La Rochelle, France
364Long-term outcomes from TVT procedures for treatment of female stress urinary incontinence: Data from a minimum of 18 years of follow-up
By: Song P.H. , Kim Y.U. , Choi J.Y. , Ko Y.H. , Moon K.H. , Jung H.C.
Institutes: College of Medicine, Yeungnam University, Dept. of Urology, Daegu, South Korea
365Correlation of presenting symptoms with explanted synthetic mid-urethral sling pathology findings
By: Patel R.S. 1 , Christie A.L. 2 , Zimmern P.E. 3
Institutes: 1U.T. Southwestern Medical Center, Dept. of Geriatrics, Dallas, United States of America, 2U.T. Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, United States of America, 3U.T. Southwestern Medical Center, Dept. of Urology, Dallas, United States of America
366Preliminary results of midurethral synthetic tape with tension control mechanism in comparison with conventional tape for female urinary stress incontinence: A randomized controlled trial
By: Sukhikh S.O. , Kasyan G.R. , Kupriyanov Y.A. , Pushkar D.Y.
Institutes: Moscow State University of Medicine and Dentistry, Dept. of Urology, Moscow, Russia
* 367Development and investigation of a tissue-engineered biodegradable mesh for the treatment of Stress Urinary Incontinence (SUI) in female patients
By: Mac Craith E. , Jose Farias Correa Do Amaral R. , Cunnane E. , Joyce M. , O'brien F. , Davis N.
Institutes: Royal College of Surgeons in Ireland, Tissue Engineering Research Group, Dublin, Ireland
368Robot-assisted artificial urinary sphincter implantation in female patients: An international multicenter study
By: Peyronnet B. 1 , Capon G. 2 , Biardeau X. 3 , Belas O. 4 , Lecoanet P. 5 , Castro-Sader L. 6 , Allue M. 6 , Hein R. 7 , Daher M. 8 , Manunta A. 1 , Robert G. 2 , Hascoet J. 1 , Dubois F. 9 , Thibault F. 10 , Cardot V. 11 , Vidart A. 12 , Descazeaud A. 13 , Fournier G. 14 , Everaerts W. 15 , Van Der Aa F. 15
Institutes: 1University of Rennes, Dept. of Urology, Rennes, France, 2University of Bordeaux, Dept. of Urology, Bordeaux, France, 3University of Lille, Dept. of Urology, Lille, France, 4Clinique Le Mans Sud, Dept. of Urology, Le Mans, France, 5University of Nancy, Dept. of Urology, Nancy, France, 6Vall Dhebron, Dept. of Urology, Barcelona, Spain, 7Magdeburg Klinik, Dept. of Urology, Magdeburg, Germany, 8Magdeburg University, Magdeburg, Germany, 9Clinique Saint-Gregoire, Dept. of Urology, Saint Grégoire, France, 10Metz Hospital, Dept. of Urology, Metz, France, 11Clinique Bizet, Dept. of Urology, Paris, France, 12Foch Hospital, Dept. of Urology, Suresnes, France, 13University of Limoges, Dept. of Urology, Limoges, France, 14University of Brest, Dept. of Urology, Brest, France, 15University of Leuven, Dept. of Urology, Leuven, Belgium
369Outcomes of laparoscopic artificial urinary sphincter in women with stress urinary incontinence
By: Schroeder A. , Tricard T. , Saussine C.
Institutes: Nouvel Hôpital Civil - Hôpitaux Universitaire de Strasbourg, Dept. of Urology, Strasbourg, France
370Real-life outcomes after artificial urinary sphincter explantation in women suffering from severe stress incontinence
By: Tricard T. , Munier P. , Schroeder A. , Saussine C.
Institutes: Nouvel Hôpital Civil - Hôpitaux Universitaire de Strasbourg, Dept. of Urology, Strasbourg, France
-
-
Industry Session by Janssen - Current scientific questions influencing patient management in advanced prostate cancer
Current scientific questions influencing patient management in advanced prostate cancer Industry Session by Janssen
Current scientific questions influencing patient management in advanced prostate cancer
Industry Session by Janssen
-
Location:Green Area, Room 1
-
Chairs:
-
Learning objectives After attending this meeting, participants should be able to:
- Describe the clinical benefits of earlier treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) and the consequences of disease progression
- Discuss the impact of new data on treatment and management decisions for individual patients with mHSPC and nmCRPC
- Recognise the roles and limitations of new imaging technologies in the diagnosis and management of patients with advanced prostate cancer
Panel discussion Current major questions influencing patient management How do the big scientific questions in advanced prostate cancer shape clinical decision making?
Rethinking mHSPC – What do we need to debate?
nmCRPC – A disease under discussion
Finding answers in the management of patients with advanced prostate cancer
-
-
-
Green Area, Room 2
-
Video Session 01 - Emerging technologies in partial nephrectomy
Emerging technologies in partial nephrectomy Video Session 01
Emerging technologies in partial nephrectomy
Video Session 01
V001Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses
By: Porpiglia F. 1 , Checcucci E. 1 , Amparore D. 1 , Piramide F. 1 , Volpi G. 1 , De Cillis S. 1 , Verri P. 1 , Manfredi M. 1 , Piazzolla P. 2 , Fiori C. 1 , Vezzetti E. 2 , Mottrie A. 3
Institutes: 1AOU San Luigi Gonzaga, Dept. of Urology, Orbassano, Italy, 2Politecnico di Torino, Dept. of Management and Production Engineering, Turin, Italy, 3OLV Hospital, Dept. of Urology, Aalst, Belgium
V002Nephron sparing surgery in patients with extension of renal cell carcinoma to the main renal vein: Intrarenal and extrarenal thrombectomy
By: Shchukin D. 1 , Lesovoy V. 1 , Polyakov M. 1 , Khareba G. 1 , Antonyan I. 2 , Maltsev A. 1 , Harahatyi A. 1
Institutes: 1Kharkiv National Medical University, Dept. of Urology, Nephrology and Andrology, Kharkiv, Ukraine, 2Kharkiv Medical Academy of Postgraduate Education, Dept. of General, Pediatric and Oncological Urology, Kharkiv, Ukraine
V003Transarterial ICG delivery before purely off-clamp robot-assisted partial nephrectomy for totally endophytic renal tumors: Technique and outcomes
By: Tuderti G. , Mastroianni R. , Anceschi U. , D'annunzio S. , Ferriero M. , Bove A. , Brassetti A. , Costantini M. , Guaglianone S. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
V004Robot assisted partial nephrectomy for hilar tumors: Technique, perioperative, oncologic and functional outcomes from a single center series
By: Ferriero M.C. , Mastroianni R. , Costantini M. , Tuderti G. , Anceschi U. , Bove A. , Brassetti A. , Guaglianone S. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
V005Laparoscopic partial nephrectomy with intra-arterial hypothermic perfusion
By: Ajami Fardoun T. , Martos R. , D'anna M. , Mercader C. , Sierra A. , Alcaraz A.
Institutes: Hospital Clinic de Barcelona, Dept. of Urology, Barcelona, Spain
V006Purely off-clamp robot-assisted partial nephrectomy for totally endophytic renal tumors: Mid-term outcomes from a single-center series
By: Tuderti G. , Mastroianni R. , Anceschi U. , D'annunzio S. , Ferriero M. , Bove A. , Brassetti A. , Costantini M. , Guaglianone S. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
-
Meeting of the EAU Section of Infections in Urology (ESIU) - Meeting of the EAU Section of Infections in Urology (ESIU)
Meeting of the EAU Section of Infections in Urology (ESIU) Meeting of the EAU Section of Infections in Urology (ESIU)
Meeting of the EAU Section of Infections in Urology (ESIU)
Meeting of the EAU Section of Infections in Urology (ESIU)
Urgent update for urologists: Fluoroquinolones in urology – Where do we stand? The standpoint of the European Medicines Agency (EMA) regarding the use of fluoroquinolones To be confirmed
Discussion
Urine tests vs patient’s symptoms – What should we use for diagnosis? To be confirmed
Discussion
Prudent antibiotic use - Antibiotic stewardship - Urosepsis Urosepsis and the role of antimicrobial stewardship programmes To be confirmed
Optimal management of urosepsis To be confirmed
Discussion
-
Thematic session 02 - Controversies in renal cancer surgery
Controversies in renal cancer surgery Thematic session 02
Controversies in renal cancer surgery
Thematic session 02
Case based debate Organ preservation: Do the benefits outweigh additional risks? V001Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses
By: Porpiglia F. 1 , Checcucci E. 1 , Amparore D. 1 , Piramide F. 1 , Volpi G. 1 , De Cillis S. 1 , Verri P. 1 , Manfredi M. 1 , Piazzolla P. 2 , Fiori C. 1 , Vezzetti E. 2 , Mottrie A. 3
Institutes: 1AOU San Luigi Gonzaga, Dept. of Urology, Orbassano, Italy, 2Politecnico di Torino, Dept. of Management and Production Engineering, Turin, Italy, 3OLV Hospital, Dept. of Urology, Aalst, Belgium
Case based debate Cytoreductive nephrectomy: What do we know? -
Thematic session 13 - Complications of renal surgery
Complications of renal surgery Thematic session 13
Complications of renal surgery
Thematic session 13
-
Location:Green Area, Room 2
-
Chairs:
-
Learning objectives Based on the previous series of thematic sessions on complications, we want to focus this year on complications of renal surgery including all type of approaches from endourology to open surgery. European experts will present typical complications and their management. Discussion of the presented cases with the audience guided by the two moderators will be an important part of the session.
-
-